Allworth Financial LP decreased its position in Ecolab Inc. (NYSE:ECL – Free Report) by 9.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 31,444 shares of the basic materials company’s stock after selling 3,187 shares during the quarter. Allworth Financial LP’s holdings in Ecolab were worth $8,761,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in ECL. Erste Asset Management GmbH grew its holdings in shares of Ecolab by 2.2% during the fourth quarter. Erste Asset Management GmbH now owns 163,731 shares of the basic materials company’s stock worth $43,464,000 after purchasing an additional 3,500 shares during the last quarter. Findlay Park Partners LLP bought a new stake in Ecolab during the 2nd quarter worth about $115,674,000. Cornerstone Advisors LLC acquired a new stake in Ecolab in the 2nd quarter valued at about $16,698,000. North Dakota State Investment Board bought a new position in shares of Ecolab in the fourth quarter worth about $2,245,000. Finally, Norges Bank acquired a new position in shares of Ecolab during the fourth quarter worth approximately $880,506,000. Institutional investors and hedge funds own 74.91% of the company’s stock.
Analysts Set New Price Targets A number of brokerages recently weighed in on ECL. BMO Capital Markets raised their price target on shares of Ecolab from $345.00 to $360.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Citigroup upped their price objective on Ecolab from $325.00 to $330.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. UBS Group reiterated a “buy” rating and issued a $342.00 price objective on shares of Ecolab in a research report on Wednesday, July 29th. Weiss Ratings raised Ecolab from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, August 31st. Finally, JPMorgan Chase & Co. boosted their target price on Ecolab from $295.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $327.56.
View Our Latest Report on ECL Insider Transactions at Ecolab In related news, EVP Benjamin Clark bought 1,000 shares of the firm’s stock in a transaction dated Thursday, June 11th. The stock was bought at an average cost of $263.83 per share, for a total transaction of $263,830.00. Following the transaction, the executive vice president owned 1,083 shares of the company’s stock, valued at $285,727.89. This represents a 1,204.82% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Christophe Beck sold 17,862 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $280.14, for a total value of $5,003,860.68. Following the completion of the sale, the chief executive officer directly owned 72,932 shares of the company’s stock, valued at approximately $20,431,170.48. This trade represents a 19.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.50% of the stock is currently owned by company insiders.
Ecolab Trading Down 0.3% ECL opened at $278.45 on Wednesday. The firm has a 50 day simple moving average of $278.85 and a 200 day simple moving average of $272.66. Ecolab Inc. has a fifty-two week low of $243.15 and a fifty-two week high of $309.27. The company has a market cap of $78.06 billion, a price-to-earnings ratio of 37.38, a price-to-earnings-growth ratio of 2.71 and a beta of 0.88. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.84 and a quick ratio of 1.57.
Ecolab (NYSE:ECL – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The basic materials company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.01. The firm had revenue of $4.42 billion for the quarter, compared to analysts’ expectations of $4.38 billion. Ecolab had a net margin of 12.57% and a return on equity of 22.72%. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. During the same period last year, the firm earned $1.89 earnings per share. Ecolab has set its Q3 2026 guidance at 2.130-2.230 EPS. On average, sell-side analysts anticipate that Ecolab Inc. will post 8.17 earnings per share for the current year.
Ecolab Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be paid a $0.73 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $2.92 annualized dividend and a yield of 1.0%. Ecolab’s dividend payout ratio is presently 39.19%.
Ecolab Company Profile (Free Report)
Ecolab Inc (NYSE:ECL) provides water, hygiene, infection prevention and technology solutions to businesses and institutions worldwide. Its customers include restaurants, hotels, hospitals, manufacturers, food and beverage companies, retailers and other organizations that rely on safe, efficient and sustainable operating environments.
The company’s offerings include cleaning and sanitizing products, water-treatment and process-management systems, food-safety programs, infection-prevention solutions and pest-elimination services.
Read More Five stocks we like better than Ecolab Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Ecolab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ecolab and related companies with MarketBeat.com's FREE daily email newsletter.
Gold (XAU/USD) rebounds on Wednesday, snapping a three-day losing streak, but struggles to extend its recovery. Tit-for-tat attacks between the United States (US) and Iran push Oil prices higher, while a rebound in the US Dollar (USD) keeps the metal below the $4,400 mark after touching a one-week low near $4,341 earlier in the day.
The US military said it destroyed five Iranian crude Oil carriers after the Islamic Revolutionary Guard Corps (IRGC) attempted to strike a US Navy warship. Tehran responded by targeting two American vessels, eight Oil tankers and another 10 ships accused of trying to pass through the Strait of Hormuz. The IRGC also said it attacked a US military base in Jordan.
West Texas Intermediate (WTI) Oil trades around $93.00 per barrel, near its highest level since June 8, and has gained about 4.25% so far this week. Markets are concerned that higher energy costs will keep inflation elevated and force major central banks, particularly the Federal Reserve (Fed), to raise interest rates. Higher borrowing costs tend to weigh on Gold by increasing the appeal of interest-bearing assets.
The benchmark 10-year US Treasury yield trades around 4.81%, near its highest level since November 2023. According to the CME FedWatch Tool, traders currently price in around a 60% chance of a 25-basis-point (bps) rate hike at next week’s meeting.
Traders now look ahead to this week’s US inflation data, with the Producer Price Index (PPI) due on Thursday and the Consumer Price Index (CPI) scheduled for Friday. The figures could bolster the case for a Fed rate hike at its September 15-16 meeting.
Hawkish Fed expectations and elevated Treasury yields help the US Dollar avoid a steeper decline. The Greenback has been under pressure from a sharp rally in the Japanese Yen (JPY), with USD/JPY hovering near 153.50, around levels last seen in February.
The US Dollar Index (DXY), which tracks the Greenback’s value against a basket of six major currencies, trades around 98.80 after touching an intraday low of 98.62, its weakest level since August 21.
Looking ahead, Gold is likely to stay sensitive to Fed rate expectations and developments in the Middle East. On Wednesday’s US economic calendar, traders await the ADP Employment Change 4-week average and details of the US Treasury’s expanded bond-buyback program taking effect at 15:00 GMT.
Technical analysis: XAU/USD holds above key 200-period SMA
On the 4-hour chart, XAU/USD holds above the 200-period Simple Moving Average (SMA) at $4,356, suggesting buyers remain active on dips. However, the 50-period SMA at $4,415 caps the immediate upside. The Relative Strength Index (RSI) stands at 47, while the Moving Average Convergence Divergence (MACD) remains slightly negative, pointing to weak momentum and a broadly neutral near-term bias.
On the upside, the 50-period SMA at $4,415 acts as the first resistance, followed by the 100-period SMA around $4,489. A break above these levels could bring the $4,550 horizontal barrier into focus, followed by $4,700.
On the downside, initial support is seen at the 200-period SMA near $4,356. A clear break below this level could intensify selling pressure and open the door toward the $4,200 support zone.
(The technical analysis of this story was written with the help of an AI tool. Know more.)
Gold FAQs Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.
Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.
Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.
The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.
Amundi cut its position in Expeditors International of Washington, Inc. (NASDAQ:EXPD – Free Report) by 24.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,047,849 shares of the transportation company’s stock after selling 336,498 shares during the quarter. Amundi owned 0.81% of Expeditors International of Washington worth $170,778,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Expeditors International of Washington by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,168 shares of the transportation company’s stock worth $1,944,000 after acquiring an additional 623 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in Expeditors International of Washington by 75.4% in the first quarter. Jones Financial Companies Lllp now owns 2,324 shares of the transportation company’s stock valued at $279,000 after acquiring an additional 999 shares during the last quarter. Woodline Partners LP increased its position in Expeditors International of Washington by 40.7% during the 1st quarter. Woodline Partners LP now owns 11,826 shares of the transportation company’s stock valued at $1,422,000 after purchasing an additional 3,420 shares during the period. Focus Partners Wealth increased its position in Expeditors International of Washington by 33.9% during the 1st quarter. Focus Partners Wealth now owns 5,227 shares of the transportation company’s stock valued at $628,000 after purchasing an additional 1,324 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Expeditors International of Washington by 29.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,113 shares of the transportation company’s stock worth $127,000 after purchasing an additional 255 shares during the last quarter. 94.02% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In A number of equities research analysts have recently commented on EXPD shares. Bank of America upped their price objective on shares of Expeditors International of Washington from $181.00 to $189.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Stephens upgraded shares of Expeditors International of Washington to a “strong-buy” rating in a report on Wednesday, July 8th. UBS Group increased their price target on Expeditors International of Washington from $191.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Truist Financial lifted their price objective on Expeditors International of Washington from $145.00 to $175.00 and gave the stock a “hold” rating in a research report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. raised Expeditors International of Washington from an “underweight” rating to a “neutral” rating and set a $200.00 price objective on the stock in a research note on Wednesday, August 5th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $168.78.
Check Out Our Latest Report on EXPD Expeditors International of Washington Price Performance EXPD stock opened at $186.05 on Wednesday. The company’s 50-day moving average is $179.43 and its 200-day moving average is $161.47. The stock has a market capitalization of $24.18 billion, a PE ratio of 32.53, a price-to-earnings-growth ratio of 5.00 and a beta of 1.06. Expeditors International of Washington, Inc. has a 1 year low of $112.94 and a 1 year high of $192.28.
Expeditors International of Washington (NASDAQ:EXPD – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The transportation company reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.34. Expeditors International of Washington had a return on equity of 36.16% and a net margin of 7.64%.During the same quarter in the prior year, the company posted $1.34 EPS. The company’s revenue for the quarter was up 32.1% compared to the same quarter last year. On average, analysts anticipate that Expeditors International of Washington, Inc. will post 5.39 earnings per share for the current fiscal year.
(Free Report)
Expeditors International of Washington is a global logistics and freight forwarding company headquartered in Seattle, Washington. The firm specializes in providing tailored supply chain solutions that encompass air, ocean and ground transportation. Through an integrated service model, Expeditors coordinates and manages the movement of goods for a diverse customer base, including manufacturers, retailers and technology companies.
The company’s core offerings include customs brokerage, cargo insurance, distribution and warehousing services, as well as vendor consolidation and inventory management.
Featured Articles Five stocks we like better than Expeditors International of Washington Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Expeditors International of Washington Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Expeditors International of Washington and related companies with MarketBeat.com's FREE daily email newsletter.
Baird Financial Group Inc. trimmed its position in Dell Technologies Inc. (NYSE:DELL – Free Report) by 14.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 233,210 shares of the technology company’s stock after selling 40,655 shares during the quarter. Baird Financial Group Inc.’s holdings in Dell Technologies were worth $100,621,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Commonwealth Retirement Investments LLC bought a new position in shares of Dell Technologies in the fourth quarter worth $25,000. Rossby Financial LCC boosted its stake in Dell Technologies by 968.4% during the fourth quarter. Rossby Financial LCC now owns 203 shares of the technology company’s stock valued at $26,000 after buying an additional 184 shares during the period. Cornerstone Financial Management LLC grew its position in Dell Technologies by 56.1% during the second quarter. Cornerstone Financial Management LLC now owns 64 shares of the technology company’s stock worth $28,000 after buying an additional 23 shares in the last quarter. Navalign LLC bought a new position in Dell Technologies in the 4th quarter worth about $29,000. Finally, Kemnay Advisory Services Inc. bought a new position in Dell Technologies in the 4th quarter worth about $29,000. 76.37% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades DELL has been the subject of a number of research analyst reports. Susquehanna set a $289.00 price target on Dell Technologies and gave the company a “neutral” rating in a research report on Friday, May 29th. Jefferies Financial Group cut shares of Dell Technologies to a “hold” rating in a research report on Monday, June 1st. William Blair initiated coverage on shares of Dell Technologies in a research note on Monday, June 1st. They issued a “neutral” rating on the stock. UBS Group reissued an “outperform” rating on shares of Dell Technologies in a research note on Wednesday, September 2nd. Finally, Citic Securities increased their price target on shares of Dell Technologies from $160.00 to $505.00 and gave the stock a “buy” rating in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Dell Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $553.79.
Read Our Latest Research Report on Dell Technologies Insider Activity In other news, Director Silver Lake Partners Iv, L.P. sold 91,191 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $517.34, for a total value of $47,176,751.94. Following the transaction, the director owned 64,209 shares in the company, valued at approximately $33,217,884.06. This trade represents a 58.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Spv-2 L.P. Sl sold 83,006 shares of Dell Technologies stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $517.34, for a total transaction of $42,942,324.04. Following the completion of the transaction, the director directly owned 73,185 shares in the company, valued at approximately $37,861,527.90. The trade was a 53.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 1,248,199 shares of company stock worth $558,352,352. Company insiders own 41.50% of the company’s stock.
Dell Technologies Price Performance Shares of DELL opened at $533.27 on Wednesday. Dell Technologies Inc. has a 1 year low of $110.22 and a 1 year high of $538.47. The stock has a 50 day simple moving average of $443.55 and a two-hundred day simple moving average of $316.11. The firm has a market cap of $345.62 billion, a P/E ratio of 30.95, a P/E/G ratio of 0.54 and a beta of 1.34.
Dell Technologies (NYSE:DELL – Get Free Report) last announced its quarterly earnings data on Tuesday, September 1st. The technology company reported $7.04 earnings per share for the quarter, topping analysts’ consensus estimates of $4.91 by $2.13. Dell Technologies had a net margin of 7.53% and a negative return on equity of 578.85%. The firm had revenue of $46.97 billion during the quarter, compared to analyst estimates of $44.89 billion. During the same period in the previous year, the business posted $1.70 EPS. The business’s quarterly revenue was up 57.7% on a year-over-year basis. Dell Technologies has set its FY 2027 guidance at 25.500-25.500 EPS and its Q3 2027 guidance at 6.500-6.500 EPS. On average, equities analysts anticipate that Dell Technologies Inc. will post 25.14 earnings per share for the current year.
Dell Technologies Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Tuesday, October 20th will be paid a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Tuesday, October 20th. Dell Technologies’s dividend payout ratio (DPR) is 14.63%.
Trending Headlines about Dell Technologies Here are the key news stories impacting Dell Technologies this week:
Positive Sentiment: Record AI server orders of $60.9 billion helped drive quarterly revenue to $46.97 billion, while earnings of $7.04 per share exceeded the $4.91 consensus estimate. The results reinforce expectations for rapid growth in AI-related infrastructure. Dell Q2 2027 Earnings Call Transcript Positive Sentiment: Coverage emphasizes that Dell is benefiting from an “on-premise” AI buildout, as enterprises install servers and AI systems internally rather than relying exclusively on public cloud providers. This broadens the potential demand opportunity beyond hyperscale data centers. Dell’s latest reinvention and on-premise AI Positive Sentiment: Analysts and financial commentators continue to raise Dell’s profile as a leading AI infrastructure investment, citing surging earnings, strong demand and the company’s roughly $95 billion AI backlog. Wall Street optimism has supported the stock’s recent momentum. Wall Street raises Dell targets after earnings Neutral Sentiment: Dell’s consumer PC business is also expanding with the lower-priced Dell 14S laptop, supported by improving PC demand. However, competition from HP and Apple limits the significance of this opportunity relative to the much larger AI server business. Dell expands consumer PC reach Negative Sentiment: At roughly $524 per share after a gain of more than 300% over the past year, valuation and execution risk are becoming more important. Investors are questioning how much of the AI backlog will convert into revenue and profitable margins, while the stock’s proximity to its high leaves less room for disappointment. Is Dell Making Money Where You Think It Is? Dell Technologies Company Profile (Free Report)
Dell Technologies Inc is a global technology company that develops, sells and supports information technology hardware, software and services. Its portfolio includes personal computers, workstations, monitors, displays, peripherals and related accessories marketed primarily under the Dell brand.
The company also provides enterprise infrastructure solutions, including servers, storage systems, networking equipment, data protection, cybersecurity and cloud-related technologies. Dell Technologies supports organizations with consulting, deployment, managed and support services designed to help them operate data centers, hybrid cloud environments and modern workplace technology.
Michael Dell founded the company in 1984 and serves as its chairman and chief executive officer.
Featured Articles Five stocks we like better than Dell Technologies Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Dell Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dell Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
Concurrent Investment Advisors LLC decreased its holdings in Cigna Group (NYSE:CI – Free Report) by 51.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 8,699 shares of the health services provider’s stock after selling 9,103 shares during the period. Concurrent Investment Advisors LLC’s holdings in Cigna Group were worth $2,398,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of CI. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Osbon Capital Management LLC purchased a new position in Cigna Group during the second quarter worth approximately $26,000. Cedar Mountain Advisors LLC lifted its position in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in Cigna Group during the second quarter worth $29,000. Finally, Fiduciary Financial Advisors acquired a new position in Cigna Group during the second quarter worth $29,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Cigna Group Trading Down 2.3% Shares of Cigna Group stock opened at $276.12 on Wednesday. The stock has a 50 day moving average of $283.56 and a 200 day moving average of $280.84. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The firm has a market capitalization of $72.96 billion, a price-to-earnings ratio of 11.42, a PEG ratio of 0.97 and a beta of 0.31. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the business earned $7.20 earnings per share. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts predict that Cigna Group will post 30.51 earnings per share for the current year. Cigna Group Announces Dividend The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 25.82%.
Insiders Place Their Bets In other news, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 23,629 shares of company stock valued at $6,561,809 over the last 90 days. 0.60% of the stock is owned by company insiders.
Analysts Set New Price Targets CI has been the subject of several analyst reports. Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Wells Fargo & Company lifted their price target on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Wolfe Research reissued an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research report on Tuesday, June 16th. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a report on Friday, July 31st. Finally, Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $339.45.
Get Our Latest Stock Analysis on Cigna Group
Cigna Group Company Profile (Free Report)
The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.
Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.
Featured Articles Five stocks we like better than Cigna Group Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
BLOOMFIELD, Conn., Sept. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 30, 2026.
HB Wealth Management LLC increased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 190.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,820 shares of the company’s stock after acquiring an additional 25,433 shares during the quarter. HB Wealth Management LLC’s holdings in Zoetis were worth $2,790,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the stock. RFG Advisory LLC boosted its position in shares of Zoetis by 4.9% in the 4th quarter. RFG Advisory LLC now owns 1,708 shares of the company’s stock valued at $215,000 after purchasing an additional 80 shares during the period. Financial Engines Advisors L.L.C. increased its position in Zoetis by 4.4% during the third quarter. Financial Engines Advisors L.L.C. now owns 2,043 shares of the company’s stock worth $299,000 after buying an additional 87 shares during the period. Physician Wealth Advisors Inc. lifted its stake in Zoetis by 17.4% in the first quarter. Physician Wealth Advisors Inc. now owns 615 shares of the company’s stock valued at $73,000 after buying an additional 91 shares during the last quarter. Smithfield Trust Co lifted its stake in Zoetis by 4.2% in the fourth quarter. Smithfield Trust Co now owns 2,294 shares of the company’s stock valued at $290,000 after buying an additional 92 shares during the last quarter. Finally, Howland Capital Management LLC boosted its holdings in shares of Zoetis by 4.5% in the second quarter. Howland Capital Management LLC now owns 2,137 shares of the company’s stock valued at $333,000 after acquiring an additional 92 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.
Wall Street Analysts Forecast Growth A number of equities analysts have recently issued reports on ZTS shares. Piper Sandler lowered their target price on shares of Zoetis from $90.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday, August 10th. Barclays reduced their price target on shares of Zoetis from $136.00 to $85.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 1st. Citigroup decreased their price target on shares of Zoetis from $112.00 to $96.00 and set a “buy” rating for the company in a research note on Tuesday, August 11th. William Blair reissued a “market perform” rating on shares of Zoetis in a research report on Thursday, August 6th. Finally, UBS Group dropped their price objective on shares of Zoetis from $85.00 to $80.00 and set a “neutral” rating on the stock in a research note on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $101.08.
Check Out Our Latest Stock Report on Zoetis Zoetis Stock Performance Shares of ZTS opened at $73.56 on Wednesday. The stock has a market capitalization of $30.40 billion, a P/E ratio of 12.12, a P/E/G ratio of 1.77 and a beta of 0.73. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.84 and a current ratio of 3.08. Zoetis Inc. has a 1 year low of $71.00 and a 1 year high of $152.12. The company’s fifty day moving average is $75.61 and its two-hundred day moving average is $92.87.
Zoetis (NYSE:ZTS – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $1.87 EPS for the quarter, topping the consensus estimate of $1.85 by $0.02. The company had revenue of $2.47 billion during the quarter, compared to analysts’ expectations of $2.50 billion. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The business’s revenue was down .2% on a year-over-year basis. During the same quarter last year, the business earned $1.76 EPS. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, sell-side analysts predict that Zoetis Inc. will post 6.2 earnings per share for the current year.
About Zoetis (Free Report)
Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.
Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.
Featured Stories Five stocks we like better than Zoetis Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.
JV to amplify both companies' complementary expertise to develop, scale, deliver differentiated crop protection solutions in high-growth markets
, /PRNewswire/ -- Corteva (NYSE: CTVA), a global leader in seed and crop protection technology, and Globachem N.V., a private company based in Belgium specializing in developing and globally marketing a wide range of crop protection products, today announced that they have entered into a definitive agreement to launch a 50/50 joint venture (JV) to support the development and delivery of new, differentiated crop protection solutions to meet evolving needs of farmers in Europe and the Americas.
The new JV will be independently operated and focus on leveraging late-pipeline to commercial-stage technology from its parent companies to amplify both companies' ability to develop, register, and market the resulting products, which may be commercialized independently by one or both parent companies.
"This is the latest example of how we're leveraging collaborations to strengthen and broaden our portfolio as we prepare to launch as a standalone crop protection company following our planned separation," said Corteva Senior Vice President Brook Cunningham. "By combining our industry-leading pipeline and innovation capabilities with Globachem's expertise in formulation, we aim to scale and accelerate the delivery of more tailored, comprehensive solutions for core crops in targeted markets."
The JV will build upon an existing, multi-year partnership between Corteva and Globachem, allowing both companies to immediately benefit through enhanced collaboration. New solutions developed by the JV are expected to launch in the early 2030s and will be sold through established commercial channels.
"The entry into a definitive agreement regarding the establishment of the JV represents an important milestone in our long-standing relationship with Corteva and reflects our shared belief that collaboration is the fastest way to bring meaningful innovation to farmers," said Koen Quaghebeur, Chief Visionary Officer and Co-founder of Globachem. "Together, Corteva's world-class discovery and development capabilities and Globachem's expertise in product development, formulation and regulatory execution, create a powerful platform for innovation. The JV will accelerate the delivery of differentiated crop protection solutions that help growers address evolving agronomic challenges and seize new opportunities. We are excited to build a company that brings together the strengths of both organizations, creating sustainable value for growers, our partners, and both parent companies."
The transaction is currently expected to close in the fourth quarter of 2026, subject to all necessary regulatory clearances and approvals.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, hightouch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
About Globachem
Globachem N.V. is a family-owned crop protection company headquartered in Belgium, committed to helping growers and distribution partners tackle some of agriculture's most critical challenges. Built on scientific expertise with a strong customer focus, the company delivers practical, user-friendly solutions through a unique portfolio of established products and innovations. Active in more than 60 countries, Globachem is a trusted long-term partner, driven by service, collaboration and a continuous search for breakthrough solutions that make a meaningful difference in key crops worldwide. Learn more at www.globachem.com.
Cautionary statement
This release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "may," "expects," "will," "aims," "believes," "intends," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the parties' expectations related to regulatory matters, product development and commercialization, product offerings and product, financial or sustainability performance are forward-looking statements. No obligation to update or revise any forward-looking statement, except as required by applicable law, is hereby undertaken and any such obligation is specifically disclaimed. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, and as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K.
Arizona State Retirement System lifted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 1.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 100,671 shares of the financial services provider’s stock after acquiring an additional 1,874 shares during the period. Arizona State Retirement System’s holdings in CME Group were worth $22,231,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Northwestern Mutual Investment Management Company LLC lifted its stake in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after purchasing an additional 37 shares during the last quarter. Rehmann Capital Advisory Group lifted its holdings in shares of CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 37 shares during the last quarter. Endowment Wealth Management Inc. lifted its holdings in shares of CME Group by 4.4% in the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock worth $244,000 after acquiring an additional 38 shares during the last quarter. NBT Bank N A NY boosted its stake in shares of CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after purchasing an additional 38 shares during the period. Finally, Resonant Capital Advisors LLC boosted its stake in shares of CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Down 1.1% Shares of NASDAQ CME opened at $278.23 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $100.05 billion, a PE ratio of 23.60, a price-to-earnings-growth ratio of 3.32 and a beta of 0.24. The stock’s fifty day simple moving average is $261.16 and its two-hundred day simple moving average is $277.88. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business’s revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.96 EPS. As a group, analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year. CME Group Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s payout ratio is 44.11%.
Insider Buying and Selling In other news, Director William Shepard acquired 325 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.30% of the company’s stock.
Analyst Ratings Changes A number of analysts recently weighed in on CME shares. Morgan Stanley increased their price objective on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. Piper Sandler reduced their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Weiss Ratings lowered CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Finally, Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $289.75.
Read Our Latest Research Report on CME Group
CME Group Company Profile (Free Report)
CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.
The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.
Featured Stories Five stocks we like better than CME Group Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
Meme coin LAPTOP, launched by Hunter Biden, son of former U.S. President Joe Biden, announced its airdrop details on social media, stating that 20% of the token’s total supply will be distributed for free to the community. 2% of LAPTOP’s total supply is reserved to compensate investors who suffered losses from Trump-themed memecoins and other related projects. This portion will be allocated to eligible users via participating exchanges, with specific eligibility criteria set by the partners. Eight percent of the total supply is earmarked for readers who were subscribed to Hunter Biden’s Substack newsletter as of September 6, 2026. Another 10% of the total supply is set aside for future community airdrops, with distribution methods determined at the sole discretion of the Phoenix Veritas Foundation. The claim portal will open concurrently with the token’s launch, scheduled for 8:00 AM ET on September 9, 2026 (20:00 Beijing Time the same day). Community members can complete their claims within 30 days of the launch.
Relevant content
Jiang Zhuoer: BTC may first rally to $84,000 before pulling back to $72,000
Jiang Zhuoer, founder of 莱比特矿池 (B.TOP), stated in a published article that BTC is currently still operating within an uptrend channel, but a subsequent correction is unavoidable. If $82,300 has become the phase high prior to this round of correction, the market may enter a prolonged period of wide-range consolidation, with prices completing adjustments through repeated fluctuations. In contrast, Jiang Zhuoer is more inclined to expect BTC to first rise further to the $83,000–$84,000 range, before correcting back to approximately $72,000.
19 minutes ago
Analysis: Bitcoin's on-chain profit structure nears the early stages of a bull market, though downside risks remain.
CryptoQuant data shows Bitcoin’s Spent Output Profit Ratio (SOPR) has stayed above the break-even line of 1 for three consecutive weeks since August 19, marking the longest such stretch since 2026, with the current reading at roughly 1.002. A SOPR above 1 indicates that BTC transferred on-chain is overall in a profitable state. On-chain analytics platform Checkonchain notes that during bear markets, price rebounds into profitable territory usually trigger sell-offs, while brief dips below the break-even line in bull markets often create dip-buying opportunities, and the current market structure is approaching the early recovery phase of a bull market. However, David Puell, portfolio manager at ARK Invest, argues Bitcoin still faces downside risks. For more conclusive evidence that the bear market has ended, SOPR needs to remain above 1 for a longer period, and BTC prices must form consecutive higher highs and higher lows.
19 minutes ago
OpenAI Partners With Samsung on Next-Generation Chips, Expanding Collaboration From Memory to Chip R&D
Beating AI News Flash: Harrison Kim, OpenAI’s head of Korea, said OpenAI is co-developing and manufacturing next-generation chips with Samsung Electronics, with clear progress made in the collaboration. He did not disclose details on the chip’s architecture, process technology, or mass production timeline. Previously, Samsung mainly served as a supplier in OpenAI’s chip roadmap. Last year, when both parties joined the Stargate Korea project, Samsung’s stated role was to provide OpenAI with advanced memory chips, as well as wafer foundry and advanced packaging capabilities. This marks the first time Samsung has explicitly entered the joint R&D and production of next-generation chips. OpenAI’s first self-developed inference chip, Jalape?o, was launched in June this year, co-developed with Broadcom and manufactured by TSMC, with deployment planned for the end of the year. OpenAI noted at the time that Jalape?o is only the first generation, with multiple subsequent chip generations to follow.
19 minutes ago
China's "four domestic GPU leaders" Suiyuan Technology will list on the Shanghai Stock Exchange's STAR Market on September 11.
China's "four leading domestic GPU startups" member Suiyuan Technology announced that its shares will be listed on the Shanghai Stock Exchange's STAR Market on September 11, 2026. As of the announcement's disclosure date, the company has not yet turned a profit, and will be included in the Sci-Tech Innovation Growth Layer upon listing. The total share capital after this offering is 430 million shares, with 17.9003 million unrestricted tradable shares at the initial listing stage, accounting for 4.1595% of the post-offering total share capital.
19 minutes ago
OpenAI and Anthropic seek investment-grade ratings ahead of their IPOs, with Wall Street beginning to lay the groundwork.
Beating AI Newsflash: Morgan Stanley and Goldman Sachs are liaising with credit rating agencies on behalf of OpenAI and Anthropic, aiming to secure investment-grade ratings for the two firms as soon as possible after their initial public offerings (IPOs). A higher rating would allow the companies to borrow at lower interest rates, while institutions like pension funds and insurers that rarely allocate to speculative-grade bonds would find it easier to enter the market, also easing pressure on their partners. Nvidia has provided up to $105 billion in credit support for OpenAI’s Ohio data center. Regulatory documents state this guarantee can be terminated once OpenAI obtains a "satisfactory credit rating"—but rating agencies have not yet budged. The Financial Times (FT) quoted rating agency analysts as saying they currently view OpenAI and Anthropic as clearly speculative-grade, noting neither has demonstrated consistent positive free cash flow. Meta, Netflix, and Tesla all waited over a decade post-IPO to secure investment-grade ratings. SpaceX, which went public this year, obtained an investment-grade rating shortly after listing, marking the first such case among large tech firms.
19 minutes ago
Anthropic's over-the-counter (OTC) market cap is currently quoted at $2.327 trillion.
HIP-3 market deployer Entropy has launched the Anthropic Pre-IPO market on Hyperliquid. ANTH rose 5.4% in 24 hours, now trading at $2,327, with a 24-hour trading volume of $14.32 million and contract open interest totaling $28.25 million.
SEA (NYSE:SE – Get Free Report) and Groupon (NASDAQ:GRPN – Get Free Report) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk.
Profitability This table compares SEA and Groupon’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets SEA 5.98% 13.54% 5.59% Groupon -25.26% N/A -20.28% Earnings & Valuation This table compares SEA and Groupon”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SEA $22.94 billion 3.02 $1.58 billion $2.59 43.82 Groupon $498.42 million 1.55 -$83.52 million ($3.11) -6.09 SEA has higher revenue and earnings than Groupon. Groupon is trading at a lower price-to-earnings ratio than SEA, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility SEA has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Comparatively, Groupon has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500.
Institutional and Insider Ownership 59.5% of SEA shares are owned by institutional investors. Comparatively, 90.0% of Groupon shares are owned by institutional investors. 0.2% of SEA shares are owned by insiders. Comparatively, 36.6% of Groupon shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Recommendations This is a summary of recent ratings and recommmendations for SEA and Groupon, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SEA 1 2 10 1 2.79 Groupon 2 1 1 0 1.75 SEA currently has a consensus price target of $149.40, suggesting a potential upside of 31.65%. Groupon has a consensus price target of $26.00, suggesting a potential upside of 37.20%. Given Groupon’s higher possible upside, analysts plainly believe Groupon is more favorable than SEA.
Summary SEA beats Groupon on 12 of the 15 factors compared between the two stocks.
About SEA (Get Free Report)
Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.
About Groupon (Get Free Report)
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
Receive News & Ratings for SEA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SEA and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of New York Mellon Corp bought a new position in shares of Groupon, Inc. (NASDAQ:GRPN – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 71,847 shares of the coupon company’s stock, valued at approximately $1,729,000. Bank of New York Mellon Corp owned 0.19% of Groupon as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Dimensional Fund Advisors LP lifted its position in shares of Groupon by 28.3% during the first quarter. Dimensional Fund Advisors LP now owns 580,873 shares of the coupon company’s stock worth $6,910,000 after acquiring an additional 128,097 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Groupon by 464.1% in the first quarter. Renaissance Technologies LLC now owns 619,413 shares of the coupon company’s stock worth $7,371,000 after buying an additional 509,600 shares in the last quarter. Bank of America Corp DE grew its stake in Groupon by 64.2% during the first quarter. Bank of America Corp DE now owns 636,480 shares of the coupon company’s stock valued at $7,574,000 after acquiring an additional 248,928 shares in the last quarter. SummitTX Capital L.P. grew its position in shares of Groupon by 432.6% during the 1st quarter. SummitTX Capital L.P. now owns 81,366 shares of the coupon company’s stock valued at $968,000 after purchasing an additional 66,088 shares in the last quarter. Finally, Pacer Advisors Inc. purchased a new position in shares of Groupon during the 1st quarter valued at $2,416,000. Institutional investors own 90.05% of the company’s stock.
Groupon Price Performance Shares of NASDAQ GRPN opened at $18.95 on Wednesday. Groupon, Inc. has a 1 year low of $9.17 and a 1 year high of $29.90. The company’s 50-day moving average is $23.68 and its 200 day moving average is $18.03. The stock has a market capitalization of $770.70 million, a P/E ratio of -6.09 and a beta of 0.24.
Groupon (NASDAQ:GRPN – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The coupon company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.02. The company had revenue of $124.67 million during the quarter, compared to analysts’ expectations of $127.09 million. Research analysts anticipate that Groupon, Inc. will post -0.14 earnings per share for the current year. Wall Street Analysts Forecast Growth Several analysts have weighed in on the company. Wall Street Zen raised Groupon from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $22.00 price objective on shares of Groupon in a research note on Monday, August 10th. Citigroup reissued an “outperform” rating on shares of Groupon in a research note on Tuesday, June 9th. Northland Securities set a $30.00 target price on shares of Groupon in a report on Monday, August 17th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Groupon in a research report on Friday. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $26.00.
Check Out Our Latest Research Report on GRPN
About Groupon (Free Report)
Groupon, Inc operates an online marketplace that connects subscribers with local merchants offering discounted goods, services and experiences. Through its website and mobile applications, Groupon provides time-limited deals across categories such as restaurants, travel, beauty and wellness, home services, and consumer products. Merchants partner with Groupon to attract new customers and drive foot traffic, leveraging the platform’s targeted marketing tools and large subscriber base to promote special offers and vouchers.
Founded in Chicago in 2008 by Andrew Mason, Eric Lefkofsky and Brad Keywell, Groupon pioneered the daily-deals model, quickly growing its user community and merchant network.
Further Reading Five stocks we like better than Groupon Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Groupon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Groupon and related companies with MarketBeat.com's FREE daily email newsletter.
Launched on May 8, 2007, the First Trust Large Cap Growth AlphaDEX ETF (FTC - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Growth segment of the US equity market.
The fund is sponsored by First Trust Advisors. It has amassed assets over $1.34 billion, making it one of the average sized ETFs attempting to match the Large Cap Growth segment of the US equity market.
Why Large Cap GrowthLarge cap companies usually have a market capitalization above $10 billion. Overall, they are usually a stable option, with less risk and more sure-fire cash flows than mid and small cap companies.
Growth stocks have higher than average sales and earnings growth rates. While these are expected to grow faster than the broader market, they also have higher valuations. Also, growth stocks are a type of equity that carries more risk compared to others. They are likely to outperform value stocks in strong bull markets but over the longer-term, value stocks have delivered better returns than growth stocks in almost all markets.
CostsCost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive counterparts if all other fundamentals are the same.
Annual operating expenses for this ETF are 0.58%, putting it on par with most peer products in the space.
It has a 12-month trailing dividend yield of 0.15%.
Sector Exposure and Top HoldingsWhile ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.
This ETF has heaviest allocation to the Information Technology sector -- about 29.9% of the portfolio. Industrials and Consumer Discretionary round out the top three.
Looking at individual holdings, Incyte Corporation (INCY) accounts for about 0.99% of total assets, followed by Dell Technologies Inc. (class C) (DELL) and Fortinet, Inc. (FTNT).
The top 10 holdings account for about 9.51% of total assets under management.
Performance and RiskFTC seeks to match the performance of the Nasdaq AlphaDEX Large Cap Growth Index before fees and expenses. The NASDAQ AlphaDEX Large Cap Growth Index is an enhanced index which employs the AlphaDEX stock selection methodology to select stocks from the NASDAQ US 500 Large Cap Growth Index.
The ETF has added roughly 11.08% so far this year and is up roughly 12.29% in the last one year (as of 09/09/2026). In the past 52-week period, it has traded between $148.93 and $194.14.
The ETF has a beta of 1.14 and standard deviation of 19.41% for the trailing three-year period, making it a medium risk choice in the space. With about 188 holdings, it effectively diversifies company-specific risk.
AlternativesFirst Trust Large Cap Growth AlphaDEX ETF holds a Zacks ETF Rank of 2 (Buy), which is based on expected asset class return, expense ratio, and momentum, among other factors. Because of this, FTC is an excellent option for investors seeking exposure to the Style Box - Large Cap Growth segment of the market. There are other additional ETFs in the space that investors could consider as well.
The Vanguard Morningstar Growth ETF (VUG) and the Invesco QQQ (QQQ) track a similar index. While Vanguard Morningstar Growth ETF has $226.74 billion in assets, Invesco QQQ has $490.17 billion. VUG has an expense ratio of 0.03% and QQQ charges 0.18%.
Bottom-LineAn increasingly popular option among retail and institutional investors, passively managed ETFs offer low costs, transparency, flexibility, and tax efficiency; they are also excellent vehicles for long term investors.
To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.
Kratos Defense & Security Solutions is rated a BUY, leveraging a fast-to-market, affordable defense model beyond drones. KTOS's growth engines include hypersonics, missile components, and satellite C2, with strong government and peer demand driving the backlog to $2.08B. Despite robust revenue growth and expanding backlog, KTOS operates with thin margins, negative free cash flow, and high CapEx, reflecting early-stage operating leverage.
New Oriental Education & Technology Group (NYSE:EDU – Get Free Report) and Coursera (NYSE:COUR – Get Free Report) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, risk, earnings, analyst recommendations, dividends and institutional ownership.
Analyst Ratings This is a breakdown of current recommendations and price targets for New Oriental Education & Technology Group and Coursera, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score New Oriental Education & Technology Group 0 2 4 1 2.86 Coursera 1 4 7 0 2.50 New Oriental Education & Technology Group currently has a consensus target price of $61.92, indicating a potential upside of 8.40%. Coursera has a consensus target price of $8.55, indicating a potential upside of 53.53%. Given Coursera’s higher possible upside, analysts clearly believe Coursera is more favorable than New Oriental Education & Technology Group.
Earnings & Valuation This table compares New Oriental Education & Technology Group and Coursera”s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio New Oriental Education & Technology Group $5.66 billion 1.59 $475.17 million $2.96 19.30 Coursera $885.40 million 1.66 -$51.00 million ($0.67) -8.31 New Oriental Education & Technology Group has higher revenue and earnings than Coursera. Coursera is trading at a lower price-to-earnings ratio than New Oriental Education & Technology Group, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership 89.6% of Coursera shares are held by institutional investors. 15.5% of New Oriental Education & Technology Group shares are held by insiders. Comparatively, 16.3% of Coursera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility New Oriental Education & Technology Group has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Coursera has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.
Profitability This table compares New Oriental Education & Technology Group and Coursera’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets New Oriental Education & Technology Group 8.39% 11.32% 5.84% Coursera -15.39% -1.72% -1.07% Summary New Oriental Education & Technology Group beats Coursera on 9 of the 15 factors compared between the two stocks.
(Get Free Report)
New Oriental Education & Technology Group, Inc. is a holding company, which engages in the provision of private educational services. It operates through the following segments: Educational Services and Test Preparation Courses, Private Label Products and Livestreaming E-Commerce, Overseas Study Consulting Services, and Educational Materials and Distribution. The company was founded by Min Hong Yu and Yong Qiang Qian on November 16, 1993, and is headquartered in Beijing, China.
About Coursera (Get Free Report)
Coursera, Inc. operates an online educational content platform in the United States, Europe, Africa, the Asia Pacific, the Middle East, and internationally. It operates in three segments: Consumer, Enterprise, and Degrees. The company offers guided projects, courses, and specializations, as well as online degrees; and certificates for entry-level professional, non-entry level professional, university, and MasterTrack. It offers its products to individuals, enterprise, business, campus, and government. The company was formerly known as Dkandu, Inc. and changed its name to Coursera, Inc. in April 2012. Coursera, Inc. was incorporated in 2011 and is headquartered in Mountain View, California.
Receive News & Ratings for New Oriental Education & Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New Oriental Education & Technology Group and related companies with MarketBeat.com's FREE daily email newsletter.
Risk appetite remained subdued on Wednesday, with equities and bonds under pressure as another leg higher in oil prices added to concerns over the deteriorating situation in the Middle East. In foreign exchange markets, the dollar was modestly firmer after initially weakening against most major currencies.
AI music startup Suno on Wednesday launched a suite of AI models in partnership with record companies Warner Music Group and BMG to allow users to generate new music inspired by licensed music of participating artists.
This move comes amid increasing scrutiny of AI music generators like Suno and Udio, as artists fret about uncompensated use of their work and streaming platforms like Deezer (DEEZR.PA) and Spotify (SPOT.N) working to improve transparency around AI-generated tracks.
Last year, Udio settled copyright lawsuits with Universal Music Group (UMG.AS) and Warner Music Group (WMG.O), while Suno settled a copyright lawsuit with Warner Music and signed licensing deals.
Suno said its flagship v6 model and the exploratory v6-Wild model will be available to both Pro and Premier tier subscribers. V6 will provide precise music generation for specific creative goals, while v6-Wild will offer results for exploration and new ideas.
Its v6-mini will be available to all users at no cost and the company expects to offer "better, faster results than any free model on any music creation platform."
"We believe this is a blueprint for how AI and the music industry can strengthen one another and build entirely new product experiences for artists, fans, and the broader music community," Suno CEO Mikey Shulman said in a statement.
Suno said last year its new models would replace previous versions to move the platform entirely onto the v6 generation.
The startup, which offers monthly Pro and Premier subscription plans in the U.S. priced at $8 and $24, respectively, had recently raised more than $400 million in a funding round that valued the startup at $5.4 billion.
"What comes next is a new kind of product we're developing: opt-in experiences built around individual artists, where artists can choose to participate and get paid when they do," Shulman, who co-founded Suno in 2022, said.
Swedish giant Spotify is also developing an AI-powered remixing tool that would let users create new versions of licensed music and share them with fans while keeping the content within the platform.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Concurrent Investment Advisors LLC boosted its position in Xcel Energy Inc. (NASDAQ:XEL – Free Report) by 81.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 29,820 shares of the company’s stock after buying an additional 13,360 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Xcel Energy were worth $2,394,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Evolution Wealth Management Inc. raised its position in shares of Xcel Energy by 365.3% during the 1st quarter. Evolution Wealth Management Inc. now owns 349 shares of the company’s stock valued at $28,000 after acquiring an additional 274 shares in the last quarter. Pin Oak Investment Advisors Inc. acquired a new position in Xcel Energy in the second quarter worth $29,000. Garton & Associates Financial Advisors LLC bought a new stake in Xcel Energy during the fourth quarter valued at $30,000. First Bancorp Inc ME bought a new stake in Xcel Energy during the second quarter valued at $36,000. Finally, Cedar Mountain Advisors LLC acquired a new stake in shares of Xcel Energy during the first quarter worth $39,000. Institutional investors and hedge funds own 78.38% of the company’s stock.
Analysts Set New Price Targets A number of research firms have recently issued reports on XEL. Morgan Stanley reduced their price target on shares of Xcel Energy from $92.00 to $89.00 and set an “equal weight” rating on the stock in a research report on Friday, August 21st. BMO Capital Markets lowered their price objective on shares of Xcel Energy from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Wednesday, July 22nd. KeyCorp reiterated an “overweight” rating on shares of Xcel Energy in a research note on Monday, June 8th. New Street Research set a $91.00 target price on shares of Xcel Energy in a report on Tuesday, June 23rd. Finally, JPMorgan Chase & Co. raised their target price on shares of Xcel Energy from $91.00 to $102.00 and gave the stock an “overweight” rating in a report on Thursday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $92.41.
View Our Latest Stock Analysis on Xcel Energy Xcel Energy Stock Performance XEL stock opened at $76.88 on Wednesday. The company has a debt-to-equity ratio of 1.49, a quick ratio of 0.62 and a current ratio of 0.70. The stock has a market capitalization of $48.02 billion, a price-to-earnings ratio of 21.06, a PEG ratio of 2.56 and a beta of 0.39. Xcel Energy Inc. has a 1 year low of $71.29 and a 1 year high of $84.23. The stock’s fifty day moving average is $78.55 and its two-hundred day moving average is $79.59.
Xcel Energy (NASDAQ:XEL – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.79 by $0.14. Xcel Energy had a net margin of 15.28% and a return on equity of 10.65%. The business had revenue of $3.12 billion during the quarter, compared to analyst estimates of $3.54 billion. During the same quarter in the prior year, the firm earned $1.59 earnings per share. The company’s quarterly revenue was down 5.1% on a year-over-year basis. On average, research analysts predict that Xcel Energy Inc. will post 4.11 EPS for the current year.
Xcel Energy Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 20th. Shareholders of record on Tuesday, September 15th will be paid a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date of this dividend is Tuesday, September 15th. Xcel Energy’s payout ratio is presently 64.93%.
Xcel Energy Profile (Free Report)
Xcel Energy (NASDAQ: XEL) is a Minneapolis-based, publicly traded utility holding company that develops, owns and operates regulated electricity and natural gas delivery systems. The company’s core activities include generation, transmission and distribution of electricity, the delivery of natural gas to customers, and related customer service operations. Xcel provides a mix of utility services to residential, commercial and industrial customers and participates in wholesale energy markets where appropriate.
Its generation portfolio combines nuclear, natural gas, coal and a growing share of renewable resources such as wind and solar.
Featured Articles Five stocks we like better than Xcel Energy Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Xcel Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xcel Energy and related companies with MarketBeat.com's FREE daily email newsletter.
Regional Management (NYSE:RM – Get Free Report) and Yirendai (NYSE:YRD – Get Free Report) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.
Analyst Recommendations This is a breakdown of current ratings and recommmendations for Regional Management and Yirendai, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Regional Management 0 2 2 0 2.50 Yirendai 1 0 0 0 1.00 Regional Management presently has a consensus price target of $43.00, suggesting a potential upside of 29.95%. Given Regional Management’s stronger consensus rating and higher probable upside, analysts plainly believe Regional Management is more favorable than Yirendai.
Earnings & Valuation This table compares Regional Management and Yirendai”s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Regional Management $645.60 million 0.47 $44.41 million $4.75 6.97 Yirendai $817.84 million 0.10 $7.80 million ($1.18) -0.83 Regional Management has higher earnings, but lower revenue than Yirendai. Yirendai is trading at a lower price-to-earnings ratio than Regional Management, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership 98.9% of Regional Management shares are held by institutional investors. Comparatively, 2.0% of Yirendai shares are held by institutional investors. 10.9% of Regional Management shares are held by insiders. Comparatively, 42.2% of Yirendai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Dividends Regional Management pays an annual dividend of $1.20 per share and has a dividend yield of 3.6%. Yirendai pays an annual dividend of $0.20 per share and has a dividend yield of 20.5%. Regional Management pays out 25.3% of its earnings in the form of a dividend. Yirendai pays out -16.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Yirendai is clearly the better dividend stock, given its higher yield and lower payout ratio.
Volatility & Risk Regional Management has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Yirendai has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500.
Profitability This table compares Regional Management and Yirendai’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Regional Management 6.98% 12.49% 2.25% Yirendai -14.35% -7.58% -5.21% Summary Regional Management beats Yirendai on 11 of the 16 factors compared between the two stocks.
(Get Free Report)
Regional Management Corp., a diversified consumer finance company, provides various installment loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders in the United States. It offers small and large installment loans; and retail loans to finance the purchase of furniture, appliances, and other retail products. The company also provides insurance products, including credit life, credit accident and health, credit property, vehicle single interest, and credit involuntary unemployment insurance; collateral protection insurance; and property insurance, as well as reinsurance products. In addition, its loans are sourced through branches, centrally-managed direct mail campaigns, and digital partners, as well as its consumer website. The company was incorporated in 1987 and is headquartered in Greer, South Carolina.
About Yirendai (Get Free Report)
Yiren Digital Ltd. provides financial services through an AI-powered platform in China. Its platform provides a suite of financial and lifestyle services. The company offers financial services, which provides a portfolio of loan products to borrowers; insurance brokerage services; and consumption and lifestyle services, including non-financial products and services to meet various consumer needs. It supports clients at various growth stages, addressing financing needs arising from consumption and production activities, and augmenting the well-being and security of individuals, families, and businesses. The company was formerly known as Yirendai Ltd. and changed its name to Yiren Digital Ltd. in September 2019. Yiren Digital Ltd. was founded in 2012 and is based in Beijing, the People's Republic of China. Yiren Digital Ltd. operates as a subsidiary of CreditEase Holdings (Cayman) Limited.
Receive News & Ratings for Regional Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regional Management and related companies with MarketBeat.com's FREE daily email newsletter.
CALGARY, Alberta – TheNewswire - September 9, 2026 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that it has achieved the first milestone under its non-dilutive Collaboration and Funding Agreement with Bayer AG (“Bayer”) dated February 10, 2026 (the “Agreement”) by submitting a complete feasibility work plan and timetable which has been approved by Bayer. (Collaboration funding news https://finance.yahoo.com/news/voyageur-pharmaceuticals-announces-collaboration-bayer-144926270.html )
Voyageur’s Houston R&D team has successfully proved out the Company’s proprietary patent-pending Mueller iodine extraction process, including laboratory production of 99.8% purity iodine from Anadarko Basin produced water. Those results provided the technical confirmation required for Bayer to advance the program. The transportable pilot plant is now nearing completion and is scheduled to enter field operation this fall. On that basis, Bayer has remitted Milestone Payment I of USD $1,000,000 to Voyageur. Together with the Initial Funds of USD $350,000 paid on March 31, 2026 following execution of the Agreement, Voyageur has now received USD $1,350,000 of the USD $2,350,000 committed by Bayer. This funding will allow Fluor to complete the FEL-3 feasibility study once the pilot plant is operational and field data are available. The remaining Milestone Payment II of USD $1,000,000 is scheduled to be released upon completion of that study.
“Achievement of this first milestone under our agreement with Bayer is an important step forward for Voyageur,” said Brent Willis, President and Chief Executive Officer of Voyageur. “It confirms that the feasibility work is advancing as planned and triggers the first major non-dilutive payment under the collaboration. This capital is expected to further accelerate our iodine supply strategy and move us closer to validating a reliable North American source of high-purity iodine for use in contrast media drugs. Combined with our Frances Creek barium project and planned drug manufacturing capabilities, this work remains central to building a secure, vertically integrated supply chain for radiology drugs.”
Subject to successful completion of the feasibility study, Bayer and Voyageur may consider advancing the project into a second phase, to negotiate a long-term offtake supply agreement. The project proposes a 1,000 tonnes per year of iodine production, with a staged production rollout, beginning with 200 tonnes per year production. Upon completion and testing of Voyageur's 200 tonnes per year iodine extraction unit (Mueller process), Voyageur may evaluate to construct and deploy 200 tonnes/year units to the field and build out over time and potentially expand capacity to 1,000 tonnes per year. In such a scenario, a central Iodine manufacturing facility would process the iodine concentrate created from the Mueller processing units, and manufacture USP Pharmaceutical grade iodine, used in manufacturing iodine contrast drugs.
The non-dilutive funding will support continued feasibility work through 2026 and reflects ongoing technical progress toward potentially establishing a domestic, high-purity iodine supply for Bayer iodine contrast drug manufacturing.
Engineering Support from Fluor
Fluor Corporation (NYSE: FLR), a leading global engineering, procurement, and construction firm, has been actively supporting Voyageur with engineering, thermodynamic modeling, and project planning. Work is progressing on schedule.
Subsequent engineering phases will progress through FEL-2 (Concept Design) and FEL-3 (Basic Design) to define a practical demonstration-scale configuration of the modular Field Unit plus Central Hub architecture. The FEL-2 phase is expected to require approximately four to five months, followed by FEL-3 of approximately seven to nine months, with corresponding increases in engineering definition and cost-estimate accuracy.
Strategic Context
Voyageur’s vertically integrated strategy aims to improve supply-chain security, reduce reliance on imported raw materials, and lower operating costs for the production of medical imaging contrast agents. The global contrast media market is estimated at approximately USD $7.06 billion. https://www.marketresearchfuture.com/reports/contrast-media-market/companies
Mr. Willis added: “Voyageur is focused on building multiple potential revenue streams through a staged commercialization strategy. This includes near-term opportunities from barium contrast sales, iodine sales under the Bayer collaboration, and longer-term opportunities from barium and iodine-based contrast drug sales. The Bayer collaboration, combined with technical support from Fluor, continues to strengthen the foundation for scalable domestic iodine production.” The Company will provide further updates as the feasibility work progresses, and additional technical milestones are achieved.
About Voyageur Pharmaceuticals Ltd.
Voyageur, a Canadian public company trading under the symbol VM on the TSXV, is in development of barium and iodine Active Pharmaceutical Ingredients (API) and intends to offer high-performance, cost-effective imaging contrast agents. With a strategic focus on vertically integrating the barium and iodine contrast markets, Voyageur aims to become a key player by producing its own barium and iodine. Voyageur has developed five barium contrast products that have Health Canada licenses.
Voyageur's business plan is set to generate cash flow by partnering with established third-party GMP pharmaceutical manufacturers in Canada thereby ensuring the validation of its products by regulatory agencies worldwide. As Voyageur solidifies its presence in the market, it plans to transition into a high-margin domestic manufacturer of radiology drugs, further expanding its revenue streams.
At the core of its operations, Voyageur owns a 100% interest in the Frances Creek barium sulfate (barite) project. Currently, the world’s pharmaceutical barium sulfate is almost entirely synthetically produced which management believes results in a less effective imaging quality product. Voyageur’s Frances Creek resource boasts a rare and high grade mineral suitable for the pharmaceutical marketplace that Voyageur believes will replace the current products with higher quality lower cost imaging products.
Voyageur's ambitious vision is to become the first vertically integrated company in the radiology contrast media drug market. By controlling all primary input costs, from the sourcing of raw materials to final production, Voyageur intends to ensure quality and cost efficiency. With its approach, it embodies the motto of "From Earth to Bottle," highlighting Voyageur's commitment to responsible sourcing and manufacturing practices.
For Further Information:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Cautionary Statement Regarding “Forward-Looking” Information
This news release may contain certain forward-looking statements and forward-looking information (collectively, "forward-looking statements"), including without limitation: the successful completion of the feasibility study for the iodine project and second milestone under the Agreement; the successful completion of the engineering phases for the iodine project; the testing, refining, market launch, manufacturing, sales and revenue from Voyageur's barium and iodine contrast products; the Company’s business plan and the Company successfully raising additional financing to support the business plan; the Company's aim to become a key player in the barium and iodine contrast markets; the Company's plan to transition into a high-margin manufacturer of radiology drugs; the Company's belief that the Frances Creek Project's mineral will replace the current synthetic products in the pharmaceutical marketplace with higher quality imaging products; and the Company's belief that it can ensure quality and cost efficiency by controlling all primary input costs. Forward-looking statements normally contain words like "will", "intend", "anticipate", "could", "should", "may", "might", "expect", "estimate", "forecast", "plan", "potential", "project", "assume", "contemplate", "believe", "shall", "scheduled", and similar terms. Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions, and other factors that management currently believes are relevant, reasonable, and appropriate in the circumstances. Although management believes that the forward-looking statements herein are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to Voyageur's business. Additional material risks and uncertainties applicable to the forward-looking statements herein include, without limitation, the impact of general economic conditions, and unforeseen events and developments. This list is not exhaustive of the factors that may affect the Company's forward-looking statements. Many of these factors are beyond the control of Voyageur. All forward-looking statements included in this news release are expressly qualified in their entirety by these cautionary statements. The forward-looking statements contained in this news release are made as at the date hereof, and Voyageur undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable securities laws. Risks and uncertainties about the Company's business are more fully discussed under the heading "Risk Factors" in its most recent filings. They are otherwise disclosed in its filings with securities regulatory authorities available on SEDAR+ at www.sedarplus.ca.
Mateřská společnost Facebooku Meta Platforms uvedla nového agenta s umělou inteligencí nazvaného Muse, který má za uživatele samostatně vykonávat úkoly.
Nový agent Muse sdílí jméno se sérií modelů, které Meta vyvíjí. Podle Mety nástroj pomůže s online nákupy, koupí lístků do kina, plánováním schůzek nebo i s vyplněním souhlasu se školním výletem.
Šéf pro AI společnosti Meta Alexandr Wang uvedl, že u méně citlivých záležitostí může Muse fungovat autonomně. Muse mu například pomáhá s organizací v úkolech, nabízí nápady na cvičení a pomáhá plánovat jídelníček. „Používám ho opravdu jako druhý mozek," řekl Wang.
Pohledy analytiků Analytici z Mizuho Securities se domnívají, že spotřebitelský AI agent Muse od Mety znamená začátek výrazného produktového cyklu, který není v ceně akcií zahrnut. Investoři podle nich chtějí u investic Mety do AI vidět návratnost a toto je významný krok tímto směrem. Analytiky pozitivně překvapila propracovanost aplikace, šíře funkcí, integrace zpravodajského feedu, schopnost provádět akce a uvedení s bezplatnou verzí.
Analytici z Morgan Stanley se budou intenzivně soustředit na to, jak se bude v čase vyvíjet adopce ze strany uživatelů a integrace dat z Facebooku, Instagramu, Messengeru a WhatsAppu do Muse Agent, protože to v kombinaci s integrací dalších monetizovatelných aplikací a personalizovaných datových sad (včetně Gmailu) může Metě dát náskok při tvorbě personalizovanějšího agenta s novými monetizovatelnými vzorci chování. Úspěch Muse není podle nich v ceně akcie zahrnut, investoři však budou muset vidět adopci a monetizovatelné chování, aby došlo k přecenění akcií výše.
Analytici z KeyBanc Capital Markets řekli, že stejně jako u ostatních aplikací Mety považují za prvotní barometr úspěchu zapojení uživatelů, monetizace podle nich přichází až časem. Analytici se nadále domnívají, že trh podceňuje pozici Mety v AI a její produktový cyklus.
Akcie Meta Platforms Akcie Meta Platforms (META) v předburzovní fázi obchodování rostou o 5,27 % na 645,81 USD.
Concurrent Investment Advisors LLC raised its position in Amcor PLC (NYSE:AMCR – Free Report) by 219.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 64,241 shares of the company’s stock after acquiring an additional 44,125 shares during the period. Concurrent Investment Advisors LLC’s holdings in Amcor were worth $2,785,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of AMCR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Amcor by 8.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 268,381 shares of the company’s stock worth $2,596,000 after buying an additional 20,757 shares during the last quarter. Focus Partners Wealth raised its stake in Amcor by 11.3% in the first quarter. Focus Partners Wealth now owns 43,137 shares of the company’s stock valued at $418,000 after buying an additional 4,396 shares during the last quarter. Sivia Capital Partners LLC acquired a new stake in Amcor in the second quarter worth about $138,000. Arrowstreet Capital Limited Partnership acquired a new stake in Amcor in the second quarter worth about $6,426,000. Finally, CW Advisors LLC purchased a new stake in shares of Amcor during the second quarter worth about $228,000. 45.14% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes Several equities analysts have recently issued reports on AMCR shares. UBS Group initiated coverage on shares of Amcor in a report on Tuesday, August 11th. They set a “buy” rating and a $56.00 price objective on the stock. Citigroup reiterated a “buy” rating and issued a $52.00 target price (up from $47.00) on shares of Amcor in a research note on Friday, August 14th. Weiss Ratings reissued a “hold (c)” rating on shares of Amcor in a research report on Friday, August 7th. Bank of America upped their price target on shares of Amcor from $48.00 to $51.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Jefferies Financial Group set a $44.92 price target on shares of Amcor and gave the stock a “hold” rating in a report on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $49.49.
Get Our Latest Report on Amcor Amcor Trading Down 1.8% NYSE AMCR opened at $44.34 on Wednesday. Amcor PLC has a 1 year low of $36.25 and a 1 year high of $50.94. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.25 and a quick ratio of 0.76. The company has a market capitalization of $20.50 billion, a PE ratio of 18.79, a P/E/G ratio of 2.47 and a beta of 0.60. The company has a fifty day moving average of $45.45 and a 200 day moving average of $42.50.
Amcor (NYSE:AMCR – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.04. The company had revenue of $6.40 billion for the quarter, compared to the consensus estimate of $6.05 billion. Amcor had a return on equity of 15.92% and a net margin of 4.71%.The firm’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period last year, the firm earned $0.20 EPS. Research analysts forecast that Amcor PLC will post 1.84 earnings per share for the current year.
Amcor Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Friday, September 4th will be issued a dividend of $0.65 per share. This represents a $2.60 annualized dividend and a yield of 5.9%. The ex-dividend date of this dividend is Friday, September 4th. Amcor’s dividend payout ratio (DPR) is 110.17%.
Amcor Company Profile (Free Report)
Amcor (NYSE: AMCR) is a global packaging company specializing in the design, development and production of flexible and rigid packaging solutions for food, beverage, pharmaceutical, medical, home and personal care, and other consumer and industrial products. The company’s product portfolio encompasses flexible films, pouches, specialty cartons, rigid containers, metal closures and dispensing systems. Amcor’s packaging solutions are engineered to preserve product quality, extend shelf life and meet the specific requirements of a wide range of end markets.
Founded in its current form in 2005 following a spin-off from a mining conglomerate, Amcor expanded its capabilities and geographic footprint through organic investments and strategic acquisitions.
Further Reading Five stocks we like better than Amcor Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Amcor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amcor and related companies with MarketBeat.com's FREE daily email newsletter.
Baird Financial Group Inc. trimmed its stake in shares of American Electric Power Company, Inc. (NASDAQ:AEP – Free Report) by 2.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 625,314 shares of the company’s stock after selling 15,798 shares during the quarter. Baird Financial Group Inc. owned approximately 0.11% of American Electric Power worth $85,549,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Costello Asset Management INC increased its position in American Electric Power by 100.0% during the 1st quarter. Costello Asset Management INC now owns 200 shares of the company’s stock valued at $26,000 after purchasing an additional 100 shares during the period. Basepoint Wealth LLC acquired a new position in shares of American Electric Power in the 4th quarter worth approximately $27,000. Union Savings Bank acquired a new position in shares of American Electric Power in the 4th quarter worth approximately $27,000. Elevation Wealth Partners LLC boosted its stake in shares of American Electric Power by 118.0% in the 2nd quarter. Elevation Wealth Partners LLC now owns 194 shares of the company’s stock valued at $27,000 after purchasing an additional 105 shares during the last quarter. Finally, Parvin Asset Management LLC bought a new stake in shares of American Electric Power in the 2nd quarter valued at $27,000. 75.24% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In AEP has been the subject of a number of analyst reports. Citigroup lowered their target price on shares of American Electric Power from $148.00 to $142.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Mizuho decreased their price target on American Electric Power from $141.00 to $135.00 and set a “neutral” rating for the company in a report on Friday, July 31st. Jefferies Financial Group lifted their price objective on American Electric Power from $147.00 to $154.00 and gave the stock a “buy” rating in a research report on Wednesday, July 1st. Truist Financial dropped their price objective on American Electric Power from $146.00 to $139.00 and set a “buy” rating on the stock in a research note on Monday, August 17th. Finally, Barclays cut their target price on American Electric Power from $138.00 to $129.00 and set an “equal weight” rating on the stock in a research report on Monday, August 3rd. Thirteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, American Electric Power currently has an average rating of “Moderate Buy” and an average target price of $140.19.
View Our Latest Analysis on American Electric Power American Electric Power Trading Up 0.7% NASDAQ:AEP opened at $125.42 on Wednesday. American Electric Power Company, Inc. has a 12 month low of $105.70 and a 12 month high of $140.58. The company has a current ratio of 0.50, a quick ratio of 0.38 and a debt-to-equity ratio of 1.44. The stock has a market capitalization of $68.28 billion, a price-to-earnings ratio of 21.51, a PEG ratio of 2.63 and a beta of 0.51. The firm has a fifty day simple moving average of $128.78 and a two-hundred day simple moving average of $130.50.
American Electric Power (NASDAQ:AEP – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.12). The company had revenue of $5.45 billion for the quarter, compared to analyst estimates of $5.34 billion. American Electric Power had a net margin of 13.78% and a return on equity of 9.95%. American Electric Power’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.43 EPS. American Electric Power has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts expect that American Electric Power Company, Inc. will post 6.39 EPS for the current fiscal year.
American Electric Power Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Monday, August 10th will be paid a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Monday, August 10th. American Electric Power’s dividend payout ratio is 65.18%.
(Free Report)
American Electric Power Company, Inc (NASDAQ:AEP) is an electric utility holding company that generates, transmits and distributes electricity to residential, commercial, industrial and other customers. Its operations include regulated electric utilities, power generation facilities and one of the largest electricity transmission networks in the United States.
AEP provides energy delivery and related utility services through operating companies serving customers across Arkansas, Indiana, Kentucky, Louisiana, Michigan, Ohio, Oklahoma, Tennessee, Texas, Virginia and West Virginia.
Read More Five stocks we like better than American Electric Power Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding AEP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Electric Power Company, Inc. (NASDAQ:AEP – Free Report).
Receive News & Ratings for American Electric Power Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Electric Power and related companies with MarketBeat.com's FREE daily email newsletter.
Concurrent Investment Advisors LLC grew its stake in shares of Main Street Capital Corporation (NYSE:MAIN – Free Report) by 294.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 49,281 shares of the financial services provider’s stock after purchasing an additional 36,785 shares during the period. Concurrent Investment Advisors LLC owned approximately 0.05% of Main Street Capital worth $2,557,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB purchased a new stake in Main Street Capital in the second quarter worth about $28,000. Smartleaf Asset Management LLC grew its holdings in shares of Main Street Capital by 109.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 478 shares of the financial services provider’s stock worth $28,000 after acquiring an additional 250 shares during the period. Sankala Group LLC purchased a new position in shares of Main Street Capital during the 4th quarter worth approximately $29,000. Gilpin Wealth Management LLC purchased a new position in shares of Main Street Capital during the 4th quarter worth approximately $31,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Main Street Capital by 181.1% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 565 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 364 shares in the last quarter. 20.31% of the stock is owned by institutional investors.
Analysts Set New Price Targets A number of research analysts have recently commented on the company. Weiss Ratings upgraded Main Street Capital from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, September 3rd. Truist Financial upped their price target on Main Street Capital from $53.00 to $57.00 and gave the stock a “hold” rating in a research note on Monday, August 10th. Wells Fargo & Company increased their price objective on Main Street Capital from $50.00 to $55.00 and gave the stock an “equal weight” rating in a report on Monday, August 10th. Zacks Research raised Main Street Capital from a “strong sell” rating to a “hold” rating in a research report on Monday, July 20th. Finally, Royal Bank Of Canada dropped their target price on shares of Main Street Capital from $66.00 to $58.00 and set an “outperform” rating on the stock in a report on Thursday, May 14th. Four investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, Main Street Capital presently has an average rating of “Hold” and an average price target of $60.83.
Check Out Our Latest Report on MAIN Main Street Capital Price Performance Shares of NYSE MAIN opened at $56.72 on Wednesday. The company has a 50 day simple moving average of $55.92 and a two-hundred day simple moving average of $54.43. Main Street Capital Corporation has a fifty-two week low of $48.95 and a fifty-two week high of $67.34. The company has a market capitalization of $5.30 billion, a price-to-earnings ratio of 11.43 and a beta of 0.72. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.05 and a current ratio of 0.05.
Main Street Capital (NYSE:MAIN – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The financial services provider reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The firm had revenue of $327.56 million for the quarter, compared to analysts’ expectations of $144.59 million. Main Street Capital had a return on equity of 11.80% and a net margin of 78.49%. Analysts expect that Main Street Capital Corporation will post 3.77 EPS for the current fiscal year.
Main Street Capital Dividend Announcement The business also recently announced a monthly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 8th will be issued a $0.265 dividend. This represents a c) annualized dividend and a yield of 5.6%. The ex-dividend date of this dividend is Tuesday, December 8th. Main Street Capital’s payout ratio is 64.11%.
Insider Buying and Selling at Main Street Capital In related news, CAO Ryan Mchugh purchased 2,550 shares of the stock in a transaction dated Thursday, August 13th. The stock was purchased at an average price of $59.05 per share, with a total value of $150,577.50. Following the transaction, the chief accounting officer directly owned 22,647 shares in the company, valued at $1,337,305.35. This trade represents a 12.69% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Jason B. Beauvais sold 6,830 shares of Main Street Capital stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $51.73, for a total value of $353,315.90. Following the completion of the transaction, the executive vice president directly owned 196,185 shares of the company’s stock, valued at approximately $10,148,650.05. This represents a 3.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.83% of the company’s stock.
Main Street Capital Company Profile (Free Report)
Main Street Capital Corporation (NYSE: MAIN) is a publicly traded business development company that provides flexible debt and equity capital to lower middle market companies in the United States. Headquartered in Houston, Texas, Main Street Capital was formed in 2007 and operates under the Investment Company Act of 1940. The firm’s management services are provided by Main Street Capital Management, L.P., which focuses on identifying growing private companies with enterprise values typically between $10 million and $150 million.
Main Street Capital’s primary offerings include first-lien senior secured loans, second-lien loans, subordinated debt, and equity co-investments or minority equity positions.
Featured Articles Five stocks we like better than Main Street Capital Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Main Street Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Main Street Capital and related companies with MarketBeat.com's FREE daily email newsletter.
MANCHESTER, England--(BUSINESS WIRE)--Manchester United plc (NYSE: MANU), announces that it will report results for the fourth quarter fiscal 2026 period ended 30 June 2026 via press release on 23 September 2026 at 7:00 AM EST. About Manchester United Manchester United is one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Earth. Through our 148-year football heritage we have won 69 trophies, enabling us to develop what we believ.
Allworth Financial LP lowered its stake in Southern Company (The) (NYSE:SO – Free Report) by 27.6% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 171,520 shares of the utilities provider’s stock after selling 65,537 shares during the quarter. Allworth Financial LP’s holdings in Southern were worth $16,416,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Marble Wealth LLC acquired a new position in shares of Southern during the fourth quarter valued at about $4,443,000. Mawer Investment Management Ltd. raised its holdings in shares of Southern by 121.4% in the 4th quarter. Mawer Investment Management Ltd. now owns 1,767,773 shares of the utilities provider’s stock worth $154,150,000 after acquiring an additional 969,493 shares during the last quarter. OMERS ADMINISTRATION Corp raised its holdings in shares of Southern by 29.2% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 50,628 shares of the utilities provider’s stock worth $4,887,000 after acquiring an additional 11,448 shares during the last quarter. MUFG Securities EMEA plc lifted its position in Southern by 114.2% in the 4th quarter. MUFG Securities EMEA plc now owns 45,112 shares of the utilities provider’s stock valued at $3,934,000 after acquiring an additional 24,056 shares in the last quarter. Finally, Glenmede Trust Co. NA lifted its position in Southern by 19.1% in the 1st quarter. Glenmede Trust Co. NA now owns 92,289 shares of the utilities provider’s stock valued at $8,908,000 after acquiring an additional 14,798 shares in the last quarter. Institutional investors and hedge funds own 64.10% of the company’s stock.
Wall Street Analysts Forecast Growth A number of analysts have commented on the company. BMO Capital Markets boosted their price objective on Southern from $102.00 to $104.00 and gave the stock an “outperform” rating in a report on Monday, July 27th. KeyCorp lowered Southern from a “sector weight” rating to an “underweight” rating and set a $79.00 target price on the stock. in a report on Thursday, July 23rd. Truist Financial cut their target price on Southern from $100.00 to $97.00 and set a “hold” rating on the stock in a research report on Thursday, August 13th. JPMorgan Chase & Co. upped their price target on Southern from $101.00 to $104.00 and gave the stock a “neutral” rating in a report on Thursday, July 16th. Finally, Barclays lowered their price target on Southern from $99.00 to $98.00 and set an “equal weight” rating for the company in a research report on Thursday, June 18th. Seven equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $100.09.
Check Out Our Latest Research Report on SO Southern Price Performance Shares of NYSE SO opened at $89.09 on Wednesday. The company has a market capitalization of $102.49 billion, a PE ratio of 21.36, a PEG ratio of 2.35 and a beta of 0.33. The company has a quick ratio of 0.59, a current ratio of 0.79 and a debt-to-equity ratio of 1.62. The stock’s 50 day moving average price is $93.09 and its 200-day moving average price is $94.21. Southern Company has a twelve month low of $83.80 and a twelve month high of $100.83.
Southern (NYSE:SO – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The utilities provider reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.12. Southern had a return on equity of 12.93% and a net margin of 15.43%.The company had revenue of $6.98 billion during the quarter, compared to the consensus estimate of $7.23 billion. During the same period last year, the business posted $0.79 earnings per share. Southern’s revenue was up .1% on a year-over-year basis. On average, equities analysts anticipate that Southern Company will post 4.59 EPS for the current year.
Southern Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 8th. Stockholders of record on Monday, August 17th were paid a dividend of $0.76 per share. This represents a $3.04 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date was Monday, August 17th. Southern’s payout ratio is presently 72.90%.
About Southern (Free Report)
Southern Company (NYSE:SO) is an energy holding company that provides electricity and natural gas services through a group of regulated utility subsidiaries. Its electric utilities generate, transmit and distribute power to residential, commercial and industrial customers, while its gas businesses distribute natural gas and provide related energy services.
The company’s principal electric subsidiaries include Alabama Power, Georgia Power and Mississippi Power. Southern Company also operates Southern Nuclear, which manages the company’s nuclear generation interests, including the Vogtle nuclear expansion in Georgia.
Featured Stories Five stocks we like better than Southern Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding SO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Southern Company (The) (NYSE:SO – Free Report).
Receive News & Ratings for Southern Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Southern and related companies with MarketBeat.com's FREE daily email newsletter.
Assay results reported for 15 drill holes comprising 6,825m of infill and expansion drilling.Consistent, wide intercepts incl. 318m @ 0.49% CuEq (162 – 480m) and 220m @ 0.40% CuEq (32-252m) with higher grades across multiple holes (incl. 12m @ 2.55% CuEq (from surface), 10m @ 1.78% CuEq and 32m @ 1.06% (from 224m)) - among the best grades drilled at Haib to date.Best 6 of 15 drill hole assay intersections as follows: • HM178:
669m @ 0.33% CuEq (53ppm Mo, 0.027g/t Au) (0 – 669m) incl.318m @ 0.49% CuEq (162 – 480m) • HM180:
732m @ 0.30% CuEq (84ppm Mo, 0.023g/t Au) (0 – 732m) incl.286m @ 0.37% CuEq (446 – 732m) and10m @ 0.45% CuEq (48 – 58m) and20m @ 0.42% CuEq (96 – 116m) and26m @ 0.61% CuEq (136 – 162m) • HMRC009:
642m @ 0.30% CuEq (96ppm Mo, 0.018g/t Au) (0 – 642m) incl.108m @ 0.40% CuEq (302 – 410m) and49m @ 0.42% CuEq (249 – 298m) • HMRC008:
558m @ 0.29% CuEq (22ppm Mo, 0.024g/t Au) (0 – 558m) incl.14m @ 0.59% CuEq (246 – 260m) • HM158:
609m @ 0.29% CuEq (61ppm Mo, 0.009g/t Au) (0 – 609m) incl.374m @ 0.34% CuEq (0 – 374m) • HM179:
261m @ 0.27% CuEq (16ppm Mo, 0.040g/t Au) (0 – 261m) incl.32m @ 1.06% CuEq (224 – 256m) LUXEMBOURG, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Koryx Copper S.A. (TSX:KRY.V) (NSX:KYX) (OTCQX:KRYXF) (“Koryx” or the "Company") is pleased to announce assay results from 15 drill holes (6,825m) received as part of the ongoing infill and expansion drill program on the wholly-owned Haib Copper Project (“Haib” or the “Project”) in southern Namibia.
Haib is a massive, disseminated porphyry Cu/Mo/Au deposit and is envisaged to produce a Cu and Mo concentrate via large-scale open pit mining and conventional sulphide milling and flotation.
Heye Daun, Koryx Copper’s President & CEO commented: “We continue to receive excellent drill assay results from our PFS infill drill program which has recently concluded. Once again, most of the drill results display very wide intercepts, including some high grades from surface. Whilst drilling has completed, assay results are still coming in and further results are expected in the next few weeks. The geological modelling and estimation for the updated MRE and PFS has commenced and we are on track to publish an MRE update and PFS study results before the end of 2026. We are very excited about how the PFS technical work is unfolding and we expect the PFS to describe a significantly optimized and improved project scope with corresponding improvements in the technical and economic metrics of the Haib copper project.”
Infill and Expansion Drill Results
Target Area 2:
Figure 1: Plan view indicating recent drill hole locations. Results indicated in black are shown on the long section below
Figure 2. Long section showing fifteen drillhole intersections relative to the model for CuEq% Intercepts
Target Area 1
HM176 was drilled in the southeast of Target 1, outside the main mineralisation. While generally a lower-tenor hole, it delivered a near-surface hit of 18m @ 0.44% Cu from 38m, including 4m @ 0.87% Cu. This correlates with HM154 (previously reported), showing further eastward extension of this mineralisation. Mo grades are low, as is typical of this area.
In line with the current model, HM184 returned several stacked mineralised zones over 452m, headlined by 28m @ 0.44% Cu from 288m and 6m @ 1.12% Cu from 442m. Molybdenum grades are low but increase with depth. Tungsten is present sporadically, with one 2m interval returning 0.375% W.
HM187 is positioned on the eastern edge of Target 1 and returned only narrow, modest-grade zones, the best being 6m @ 0.36% Cu from 130m. Molybdenum is low-grade throughout.
HMRC004 is located in the north of Target 1 and correlates with the existing copper model, starting in high-grade material with 6m @ 1.27% Cu from 0m, followed by a broader 66m @ 0.31% Cu from 62m. Molybdenum is largely absent, while gold is evident, with two samples returning 0.216g/t and 0.156g/t over 2m respectively.
HMRC007 returned consistent, moderate-grade mineralisation in multiple zones from surface to depth, the widest being 52m @ 0.29% Cu from 232m, including 6m @ 0.54% Cu from 276m. As this is an infill hole, results are largely in line with expectations, although the 26m @ 0.29% Cu from 434m is some 70m vertically below the limit of the current Cu model and represents, to some extent, new mineralisation. Mo is absent, while Au is present at slightly elevated levels deeper in the borehole, providing support to the CuEq grade at depth.
HMRC008 is an infill hole showing excellent Cu mineralisation from surface, with 12m @ 2.39% Cu from surface, including 2m @ 8.01% Cu (the highest grade returned yet at Haib) from 4m. Deeper, multiple Cu zones are reported, the widest of which are 94m @ 0.32% Cu from 16m and 22m @ 0.42% Cu. W is present sporadically, the best of which is 6m @ 0.064% W.
Target Area 2
HM158 was drilled northwards from the centre of Target 2 and returned 374m @ 0.30% Cu from surface. Multiple higher-grade intervals (≥0.37% Cu) are present, varying in thickness from 4m to 14m. Results for Cu are largely as expected. Mo starts relatively low but is well developed between 60m and 300m, providing significant support to the CuEq value here.
HM178 is one of the standout holes, with a broad 318m @ 0.44% Cu from 162m, including 10m @ 0.92% Cu from 214m and 8m @ 1.06% Cu from 240m. Averaging 0.29% Cu over its full 669m, molybdenum is well developed from 160m down the hole, providing good support for the CuEq. Gold is also present, with two 4m intervals returning >0.1g/t Au. Tungsten occurs sporadically in multiple narrow zones, with grades between 0.012% and 0.022% W.
HM179 was drilled in the south of Target 2 and delivered high-grade copper only at the base of the hole: 32m @ 0.96% Cu from 224m, including 10m @ 1.65% Cu from 234m. This zone is also associated with gold, returning two 4m intervals at 0.10g/t and 0.13g/t Au, as well as 10m @ 0.18g/t Au. This is one of the highest-grade Cu and Au intersections returned yet at Haib, and its location, some 70m south of the current Cu model, points to an as-yet-undetected lobe of high-grade mineralisation, though its impact on mineral resources still needs to be determined. Mo is absent for the entire hole.
HM180 is an infill hole that was oriented to intersect the deepest parts of known Target 2 mineralisation, which it has done, correlating well with the existing copper model. Within the first 160m, Cu grades are high, with multiple zones at about 0.4% Cu and higher, the best of which is 26m @ 0.55% Cu. The widest intersection, 286m @ 0.31% Cu from 446m, is associated with high-grade molybdenum (starting at ~160m), which materially enhances the CuEq grade. Tungsten is present throughout, with the best interval being 8m @ 0.211% W.
HM188 was drilled south of known mineralisation to better define the margin of mineralisation and returned no significant intersections of copper, molybdenum, or gold. However, between 150m and 200m, tungsten is quite common, with the best return being 8m @ 0.116% W.
HMRC001 is located in the centre of Target 2 and intersected mineralisation from surface, with 12m @ 0.74% Cu from near surface, including 4m @ 0.98% Cu. The widest intersection, 220m @ 0.35% Cu from 32m, contains multiple intervals at ~0.4% Cu and higher, along with relatively high molybdenum grades. Overall, copper results correlate well with the existing model. Tungsten is present sporadically throughout, with the best interval returned being 12m @ 0.017% W.
HMRC003 is an infill hole located near the northern boundary of Target 2. It opened with 76m @ 0.33% Cu from surface, including 10m @ 0.58% Cu from 36m. Overall, results are in line with the current model.
HMRC009 is a centrally located borehole that intersected multiple broad zones over its length, the widest of which were 108m @ 0.34% Cu from 302m and 49m @ 0.37% Cu, including 4m @ 1.08% Cu. Molybdenum is well developed throughout, bolstering the CuEq grade.
HMRC011 is located south of the known Target 2 mineralisation. Results show this hole to be weakly mineralised with respect to Cu. The intersection of 8m @ 0.41% Cu from 324m (with Mo @ 221ppm) is still well south of Target 2 and may represent a peripheral, mineralised, cross-cutting structure.
Table of Significant Intersections
Hole#ZoneFrom (m)To (m)Width (m)1Cu (%)Mo (ppm)Au (g/t)CuEq (%)2HM158X: 781666, Y 6822670, Z: 429, Azimuth: 015, Dip: -61, Depth 610 HM158Entire Hole06096090.26610.0090.29Main03743740.30880.0090.34Including121860.48430.0040.49Including5868100.392020.0050.46Including11612480.43620.0180.46Including14615260.48280.0200.51Including18819680.471010.0150.52Including21221640.348420.0160.65Including286300140.373730.0160.51Including32433060.71400.0180.74Main416428120.3030.0110.31Main464482180.33250.0190.36HM176X: 782220, Y 6821988, Z: 572, Azimuth: 013, Dip: -80, Depth 204 HM176
Entire Hole02042040.12110.0180.13Main3856180.44200.0530.49Including465040.87640.0760.95HM178X: 781637, Y 6822490, Z: 489, Azimuth: 023, Dip: -59, Depth 669 HM178
Entire Hole06696690.29530.0270.33Main3058280.32220.0250.34Including344060.55270.0340.58Main11412060.36350.0310.39Main138148100.4040.0350.42Main1624803180.44890.0320.49Including214224100.924010.1141.15Including224240160.68550.0590.75Including24024881.061250.0681.15Including254264100.472480.0390.59Including36637480.451080.0260.51Including42443280.461300.0270.53Including452462100.69530.0310.73Main528552240.31180.0310.34HM179X: 781574, Y 6822207, Z: 549, Azimuth: 195, Dip: -59, Depth 261 HM179
Entire Hole02612610.24160.0400.27Main224256320.96490.1151.06Including234244101.6570.1771.78HM180X: 781484, Y 6822542, Z: 487, Azimuth: 023, Dip: -72, Depth 732 HM180
Entire Hole07327320.26840.0230.30Main4858100.42320.0310.45Main96116200.39300.0300.42Main136162260.55620.0500.61Including15215640.88740.0860.97Main162188260.231720.0190.30Main202218160.213020.0180.33Main242266240.28460.0340.32Including24624820.943440.0871.13Main278294160.27620.0180.31Main384410260.31880.0270.36Including38839460.45860.0380.51Main4467322860.311080.0240.37Including48849460.443190.0400.59Including654664100.432810.0260.55Including67267860.51770.0250.56Including68469060.512310.0350.62Including71071880.401620.0290.48HM184X: 782071, Y 6822357, Z: 438, Azimuth: 191, Dip: -72, Depth 452 HM184
Entire Hole04524520.22420.0180.25Main3246140.32490.0330.36Main5264120.29400.0270.32Main94110160.45200.0290.48Main244272280.39410.0200.42Including25025220.85750.0350.90Including25625821.96480.0932.04Main288316280.44810.0350.50Including29029660.75670.0500.81Main40241080.491970.0360.58Including40240640.671870.0430.77Main44244861.121420.0461.21HM187X: 782234, Y 6822415, Z: 425, Azimuth: 191, Dip: -65, Depth 332 HM187
Entire Hole03323320.13180.0150.14Main162260.34240.0210.36Main13013660.36110.0300.38Main184194100.27850.0300.32HM188X: 781520, Y 6822141, Z: 578, Azimuth: 192, Dip: -60, Depth 204 Entire Hole02042040.12350.0150.14HMRC0013X: 781445, Y 6822953, Z: 408, Azimuth: 038, Dip: -87, Depth 459 HMRC001
(previously reported to 243m)
Entire Hole04594590.30750.0190.34Main416120.741280.0240.81Including101440.981960.0281.07Main322522200.35990.0200.40Including465260.542010.0170.63Including12413060.613020.0250.73Including13614480.511710.0330.60Including16416840.491930.0230.58Including19419840.58700.0290.63Including23624040.49220.0270.52Main262282200.281590.0100.34Main312378660.32480.0170.35Including362376140.43490.0200.46HMRC0033X: 781538, Y 6823129, Z: 426, Azimuth: 018, Dip: -67, Depth 446 HMRC003
(previously reported to 138m)
Entire Hole04464460.20510.0110.23Main076760.33690.0110.37Including3646100.58610.0120.61Main232242100.303190.0110.43Main266280140.31730.0170.35HMRC0043X: 781974, Y 6822625, Z: 390, Azimuth: 188, Dip: -77, Depth 411 HMRC004
(previously reported to 243m)
Entire Hole04114110.2080.0330.22Main0661.27160.0131.29Main62128660.31120.0490.35Including6476120.54460.0780.61HMRC0073X: 781876, Y 6822579, Z: 419, Azimuth: 186, Dip: -86, Depth 504 HMRC007
(previously reported to 231m)
Entire Hole05045040.22130.0300.24Main0660.3890.0220.39Main142060.30640.0240.34Main243280.27510.0260.30Main404880.32190.0280.35Main102112100.3690.0370.39Main214231170.3990.0560.44Main232284520.29120.0450.33Including27628260.54120.0500.58Main36237080.3770.0270.39Main434460260.2930.0390.32HMRC0083X: 781833, Y 6822527, Z: 439, Azimuth: 225, Dip: -86, Depth 558 HMRC008
(previously reported to 231m)
Entire Hole05585580.27220.0240.29Main012122.391350.1482.55Including4628.013300.3428.38Main16110940.32290.0280.35Including485460.58250.0410.62Including10010660.59790.0530.65Main180202220.42110.0410.45Including190200100.57140.0530.61Main216230140.4260.0570.47Including22422840.7290.0790.78Main246260140.482340.0380.59HMRC0093X: 781525, Y 6822814, Z: 437, Azimuth: 039, Dip: -85, Depth 642 HMRC009
(previously reported to 243m)
Entire Hole06426420.25960.0180.30Main028280.44770.0300.49Including21080.641100.0360.71Main70146760.241610.0180.31Including808660.361420.0190.43Main170184140.302390.0200.40Including18018440.444600.0290.63Main196214180.271640.0190.34Main249298490.371180.0160.42Including26627041.082510.0421.20Main3024101080.341200.0210.40Including34635040.641580.0390.73Including38839240.93750.0490.99Main428464360.311510.0240.38Including45846240.78470.0410.82HMRC011X: 781382, Y 6822347, Z: 573, Azimuth: 018, Dip: -80, Depth 345 HMRC011
Entire Hole03453450.10400.0140.13Main32433280.412210.0400.52 Legend:%CuMo(ppm)Au (g/t)%CuEq<0.4<100<0.10<0.40.4 - 0.5100 - 200≥ 0.100.4 - 0.50.5 - 0.7200 - 1,000 0.5 - 0.70.7 - 1.0≥ 1,000 0.7 - 1.01.0 - 3.0 1.0 - 3.0≥ 3.0 ≥ 3.0 True widths are unknown. Widths are interval widths and not true widths. The reported intervals are calculated using the following parameters: Only CuEq (%) was used to determine the intervals.The target composite grade is ≥0.30% CuEq.Composites start and end with samples ≥0.30% CuEq.Grades between 0.20% and 0.30% are included in interval but generally constitute <40% of the interval.Consecutive samples between 0.20% and 0.30% should be fewer than 5 samples (10m).Grades below 0.20% are included but generally constitute <20% of the interval.Consecutive grades <0.2% should be fewer than 2 samples (4m). Mineral Resource (MRE) copper equivalent (CuEq%) values have been calculated using commodity type and price considering the relevant recovery rate. The following metal prices were used Cu US$4.54/lb; Mo US$22.68/lb; Au US$4,000/oz along with the following recoveries indicated from test work, Cu 89%; Mo 65% and Au 50%. The CuEq was then calculated using CuEq = [(Cu grade/100 * 0.89 Cu recovery * 2204.62 * $4.54 Cu price/lb) + (Mo ppm/1000000 * 0.65 Mo recovery * 2204.62 * $22.68 Mo price/lb) + (Au grade * 0.50 Au recovery * 4000 Au price/oz / 31.1035)] / [0.89 Cu Recovery * 2204.62 * $4.54 Cu price/lb]Partial results previously reported. Quality Assurance / Quality Control
All drill core is HQ sized at collar and reduced to NQ size in fresh rock. The core was all logged, photographed, and cut in half with a diamond saw. Half of the core was bagged and sent to ALS Laboratories Ltd. in Johannesburg, South Africa for analysis (SANAS Accredited Testing Laboratory, No. T0387) and ActLabs in Canada, while the other half was quartered with one quarter archived and stored on site for verification and reference purposes while the other quarter will be used for metallurgical test work. 33 elements are analyzed by Inductively Coupled Plasma (ICP) utilizing a 4-acid digestion and gold is assayed for using a 30g fire assay method. Duplicate samples, blanks, and certified standards are included with every batch and are actively used to ensure proper quality assurance and quality control (“QA/QC”) The QA/QC frequency is 1 in 20 for each of blanks, duplicates and standards.
Qualified Persons
Mr. Dean Richards, BSc. (Hons) Geology, Pr.Sci.Nat., MGSSA – is the Qualified Person for the Haib Copper Project and has reviewed and approved the scientific and technical information in this news release and is a registered Professional Natural Scientist with the South African Council for Natural Scientific Professions (Pr.Sci.Nat. No. 400190/08). Mr. Richards is independent of the Company and its mineral properties and is a Qualified Person for the purposes of National Instrument 43-101.
About Koryx Copper S.A.
Koryx Copper S.A. is a Luxembourg domiciled copper development Company focused on advancing its 100% owned Haib Copper Project in Namibia whilst also building a portfolio of copper exploration licenses in Zambia. Haib is a large copper porphyry deposit in southern Namibia with significant gold and molybdenum credits and a long history of exploration and project development by multiple operators.
More than 155,000m of drilling has been conducted at Haib since the 1970’s with significant exploration programs led by companies including Falconbridge (1964), Rio Tinto (1975), Teck (2014) and Koryx Copper (2021-2026). Extensive further drilling, metallurgical testing and various technical studies have been completed at Haib. Additional studies are underway aiming to demonstrate Haib as a future long-life, low-cost, low-risk open pit, sulphide milling and flotation copper project with additional heap leach potential.
Mineralisation at Haib is typical of a porphyry copper deposit and is dominantly chalcopyrite with minor bornite and chalcocite present and only minor secondary copper minerals at surface due to the arid environment. Haib is one of only a few examples of a Paleoproterozoic porphyry copper deposit in the world. Due to its age, the deposit has been subjected to multiple metamorphic and deformation events but still retains many of the classic mineralisation and alteration features typical of these deposits.
Further details of the Haib Copper Project are available in the technical report titled “March 2026 Mineral Resource Estimate Haib Copper Project, Namibia, National Instrument 43-101 Technical Report” dated effective March 16, 2026. The report and other information are available on the Company's website at www.koryxcopper.com and under the Company's profile on SEDAR+ at www.sedarplus.ca.
Additional information is also available by contacting the Company:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the future or prospects of the Haib project or the Company, including prospective production rates and life-of-mine, the timing of publishing a PFS, the commencement of trading of the Shares under the new Company name, and the effective date of the new CUSIP and ISIN assigned to the Shares. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect ", "is expected ", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market, and economic risks, uncertainties, and contingencies that may cause actual results, performance, or achievements to be materially different from those expressed or implied by forward-looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, other factors may cause results not to be as anticipated, estimated, or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Other factors which could materially affect such forward-looking information are described in the risk factors in the Company's most recent annual management discussion and analysis. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/e9ce5ad2-4deb-49bd-97b1-e8bfc6241d69
https://www.globenewswire.com/NewsRoom/AttachmentNg/87bff72f-3fdf-43c8-99f0-fc5e465e1bf7
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (NYSE:UWMC) and certain of the company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.
If you invested in UWM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/uwm-holdings-class-action-lawsuit.
Key Details of the UWM ($UWMC) Class Action:
Lead Plaintiff Deadline: October 13, 2026Alleged Misconduct: Securities fraud alleging that UWM misrepresented its mortgage servicing rights hedging strategy and the risks created by hedging connected to the Two Harbors transactionStock Drop: August 6, 2026 – 34.78% Stock DropCourt: U.S. District Court for the Eastern District of MichiganAction: Contact BFA Law to discuss your rights Investors have until October 13, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in UWM securities. The class action is pending in the U.S. District Court for the Eastern District of Michigan. It is captioned Bond v. UWM Holdings Corporation et al., No. 26-cv-12862.
Why is UWM Being Sued for Securities Fraud?
UWM originates, sells, and services residential mortgage loans in the United States. In December 2025, UWM and Two Harbors Investment Corp., owner of RoundPoint Mortgage Servicing, signed an all-stock merger agreement valued at $1.3 billion.
According to the complaint, in March 2026, Two Harbors terminated the UWM agreement after CrossCountry Mortgage made a competing cash offer and agreed to pay UWM’s termination fee.
As alleged, UWM failed to disclose that it had deviated from its traditional strategy of not hedging its mortgage servicing rights by taking a major hedge position, that it over-hedged itself in anticipation of the Two Harbors transaction, and that its purported efforts to balance risk created excess hedging risk.
Why did UWM’s Stock Drop?
On August 5, 2026, after the market closed, UWM reported Q2 2026 financial results, including a $603.2 million interest rate derivatives loss which contributed to a $451.9 million second-quarter net loss. Total equity also fell 43.6% year over year, reflecting the net loss and derivative-related charges.
Then, on August 6, 2026, UWM disclosed that it “over-hedged” while protecting against the Two Harbors transaction and stated that UWM does not traditionally hedge its mortgage servicing rights. UWM further disclosed that when it was acquiring Two Harbors and a large mortgage servicing rights book, “it created a little more risk,” that UWM “did put a hedge on to protect against that risk,” and that “the Two Harbors transaction went away,” creating a hedge loss. On this news, UWM’s stock dropped $0.64 per share, or 34.78%, from a closing price of $1.84 per share on August 5, 2026, to $1.20 per share on August 6, 2026.
Click here for more information: https://www.bfalaw.com/cases/uwm-holdings-class-action-lawsuit.
What Can You Do?
If you invested in UWM, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360, and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
BFA’s notable successes include a recovery of over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
EMCOR Group (NYSE:EME – Get Free Report) and Southland (NASDAQ:SLND – Get Free Report) are both industrials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.
Volatility and Risk EMCOR Group has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Southland has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.
Institutional and Insider Ownership 92.6% of EMCOR Group shares are owned by institutional investors. Comparatively, 2.8% of Southland shares are owned by institutional investors. 0.7% of EMCOR Group shares are owned by insiders. Comparatively, 73.4% of Southland shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Analyst Ratings This is a breakdown of recent recommendations and price targets for EMCOR Group and Southland, as provided by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EMCOR Group 0 1 8 1 3.00 Southland 0 1 0 0 2.00 EMCOR Group currently has a consensus target price of $965.86, indicating a potential upside of 25.06%. Given EMCOR Group’s stronger consensus rating and higher probable upside, research analysts clearly believe EMCOR Group is more favorable than Southland.
Profitability This table compares EMCOR Group and Southland’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets EMCOR Group 7.74% 35.49% 14.12% Southland -10.38% -47.71% -8.75% Valuation and Earnings This table compares EMCOR Group and Southland”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EMCOR Group $16.99 billion 2.01 $1.27 billion $32.15 24.02 Southland $603.01 million 0.06 -$19.25 million ($7.46) -0.08 EMCOR Group has higher revenue and earnings than Southland. Southland is trading at a lower price-to-earnings ratio than EMCOR Group, indicating that it is currently the more affordable of the two stocks.
Summary EMCOR Group beats Southland on 14 of the 15 factors compared between the two stocks.
About EMCOR Group (Get Free Report)
EMCOR Group, Inc. provides construction and facilities, building, and industrial services in the United States and the United Kingdom. It offers design, integration, installation, start-up, operation, and maintenance services related to power transmission, distribution, and generation systems; energy solutions; premises electrical and lighting systems; process instrumentation; low-voltage systems; voice and data communications systems; roadway and transit lighting, signaling, and fiber optic lines; computerized traffic control systems, and signal and communication equipment; heating, ventilation, air conditioning, refrigeration, and geothermal solutions; clean-room process ventilation systems; fire protection and suppression systems; plumbing, process, and high-purity piping systems; controls and filtration systems; water and wastewater treatment systems; central plant heating and cooling systems; crane and rigging services; millwright services; and steel fabrication, erection, and welding services. The company also provides building services that covers commercial and government site-based operations and maintenance; facility management, maintenance, and services; energy efficiency retrofit services; military base operations support services; services for indoor air quality; floor care and janitorial services; landscaping, lot sweeping, and snow removal services; vendor management and call center services; installation and support for building systems; program development, management, and maintenance for energy systems; technical consulting and diagnostic services; infrastructure and building projects; modification and retrofit projects; and other building services, including reception, security, and catering services. In addition, it offers refinery turnaround planning and engineering; welding; overhaul and maintenance; instrumentation and electrical; and renewable energy services. The company was incorporated in 1987 and is headquartered in Norwalk, Connecticut.
About Southland (Get Free Report)
Southland Holdings, Inc. engages in specialty infrastructure construction business in North America and internationally. The company operates through two segments, Civil and Transportation. The Civil segment designs and constructs water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The Transportation segment designs and constructs bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities, as well as convention centers, sports stadiums, marine facilities, and ferris wheels. Southland Holdings, Inc. was founded in 1900 and is headquartered in Grapevine, Texas.
Receive News & Ratings for EMCOR Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EMCOR Group and related companies with MarketBeat.com's FREE daily email newsletter.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Kyocera (OTCMKTS:KYOCY – Get Free Report) and Cognex (NASDAQ:CGNX – Get Free Report) are both large-cap technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.
Earnings and Valuation This table compares Kyocera and Cognex”s revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kyocera $13.75 billion 2.41 $936.46 million $0.67 36.70 Cognex $994.36 million 10.53 $114.44 million $1.03 60.42 Kyocera has higher revenue and earnings than Cognex. Kyocera is trading at a lower price-to-earnings ratio than Cognex, indicating that it is currently the more affordable of the two stocks. Insider and Institutional Ownership 7.4% of Kyocera shares are held by institutional investors. Comparatively, 88.1% of Cognex shares are held by institutional investors. 1.7% of Cognex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Dividends Kyocera pays an annual dividend of $0.12 per share and has a dividend yield of 0.5%. Cognex pays an annual dividend of $0.34 per share and has a dividend yield of 0.5%. Kyocera pays out 17.9% of its earnings in the form of a dividend. Cognex pays out 33.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognex has increased its dividend for 10 consecutive years. Cognex is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Analyst Recommendations This is a summary of current ratings for Kyocera and Cognex, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kyocera 0 1 0 0 2.00 Cognex 0 5 10 2 2.82 Cognex has a consensus target price of $75.64, suggesting a potential upside of 21.55%. Given Cognex’s stronger consensus rating and higher possible upside, analysts plainly believe Cognex is more favorable than Kyocera.
Profitability This table compares Kyocera and Cognex’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Kyocera 6.78% 4.17% 3.04% Cognex 16.05% 13.50% 10.02% Risk and Volatility Kyocera has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Cognex has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500.
Summary Cognex beats Kyocera on 15 of the 18 factors compared between the two stocks.
About Kyocera (Get Free Report)
Kyocera Corporation develops, produces, and distributes products based on fine ceramic technologies in Japan, rest of Asia, Europe, the United States, and internationally. It operates through Core Components Business, Electronic Components Business, and Solutions Business segments. The Core Components Business segment offers components, such as fine ceramic components for semiconductor processing equipment, automotive camera modules, and ceramic packages, as well as organic packages and boards to protect electronic components and ICs to industrial machinery, automotive-related, and the information and communication-related markets; optical components, and jewelry and applied ceramic related products; and medical devices comprising prosthetic joints and dental implants. The Electronic Components Business segment provides various electronic components and devices, including capacitors, crystal devices, connectors, and power semiconductor devices for diverse fields comprising information and communications, industrial equipment, automotive-related, and consumer markets, as well as sensors and control components. The Solutions Business segment offers cutting tools, as well as pneumatic and power tools for automotive-related and general industrial, and construction markets; printers for offices; and communication terminals, such as mobile phones, as well as information systems and telecommunication services. This segment also provides MFPs, commercial inkjet printers, communication modules, displays, and printing devices, as well as information systems and telecommunication, smart energy-related products and services, and solution services, such as document management system. The company was formerly known as Kyoto Ceramic Kabushiki Kaisha and changed its name to Kyocera Corporation in 1982. Kyocera Corporation was incorporated in 1946 and is headquartered in Kyoto, Japan.
About Cognex (Get Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to automotive, logistics, consumer electronics, medical-related, semiconductor, consumer products, food and beverage, and others, as well as through a network of distributors and integrators. The company was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Receive News & Ratings for Kyocera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyocera and related companies with MarketBeat.com's FREE daily email newsletter.
Herc Holdings (HRI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
WM Technology (NASDAQ:MAPS – Get Free Report) and Akamai Technologies (NASDAQ:AKAM – Get Free Report) are both technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.
Profitability This table compares WM Technology and Akamai Technologies’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets WM Technology 1.12% 1.51% 1.04% Akamai Technologies 9.51% 11.32% 4.47% Analyst Ratings This is a summary of current ratings and recommmendations for WM Technology and Akamai Technologies, as reported by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WM Technology 1 0 0 0 1.00 Akamai Technologies 2 9 13 0 2.46 Akamai Technologies has a consensus price target of $141.62, indicating a potential upside of 34.10%. Given Akamai Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Akamai Technologies is more favorable than WM Technology. Insider & Institutional Ownership 22.0% of WM Technology shares are owned by institutional investors. Comparatively, 94.3% of Akamai Technologies shares are owned by institutional investors. 19.7% of WM Technology shares are owned by insiders. Comparatively, 2.3% of Akamai Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation This table compares WM Technology and Akamai Technologies”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WM Technology $174.70 million 0.34 $1.96 million $0.02 18.63 Akamai Technologies $4.32 billion 3.51 $452.03 million $2.78 37.99 Akamai Technologies has higher revenue and earnings than WM Technology. WM Technology is trading at a lower price-to-earnings ratio than Akamai Technologies, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk WM Technology has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, Akamai Technologies has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.
Summary Akamai Technologies beats WM Technology on 12 of the 14 factors compared between the two stocks.
About WM Technology (Get Free Report)
WM Technology, Inc. provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. The company offers Weedmaps marketplace that allows cannabis users to search for and browse cannabis products from retailers and brands, and reserve products from local retailers; and education and learning information to help newer consumers learn about the types of products to purchase. It also provides monthly subscription-based business software solutions, including WM Listings, WM Orders, WM Store, WM Connectors, and WM Insights as well as other add-on products, such as WM Ads, WM AdSuite, WM Customer Relationship Management, WM Dispatch, and WM Screens. WM Technology, Inc. was founded in 2008 and is headquartered in Irvine, California.
(Get Free Report)
Akamai Technologies, Inc. provides cloud computing, security, and content delivery services in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance. It also provides web and mobile performance solutions to enable dynamic websites and applications; media delivery solutions, including video streaming and video player services, game and software delivery, broadcast operations, authoritative domain name system, resolution, and data and analytics; and cloud computing services, such as compute, storage, networking, database, and container management services to build, deploy, and secure applications and workloads. In addition, the company offers content delivery solutions; and an array of service and support to assist customers with integrating, configuring, optimizing, and managing its offerings. It sells its solutions through various channel partners. Akamai Technologies, Inc. was incorporated in 1998 and is headquartered in Cambridge, Massachusetts.
Receive News & Ratings for WM Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WM Technology and related companies with MarketBeat.com's FREE daily email newsletter.
HB Wealth Management LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 16.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,446 shares of the company’s stock after selling 1,282 shares during the period. HB Wealth Management LLC’s holdings in HCA Healthcare were worth $2,513,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the stock. Saudi Central Bank raised its holdings in HCA Healthcare by 85.8% during the second quarter. Saudi Central Bank now owns 10,955 shares of the company’s stock worth $4,271,000 after purchasing an additional 5,059 shares in the last quarter. AlphaGrep UK Ltd acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $1,079,000. Premier Path Wealth Partners LLC lifted its holdings in shares of HCA Healthcare by 6.4% in the second quarter. Premier Path Wealth Partners LLC now owns 2,450 shares of the company’s stock valued at $955,000 after buying an additional 148 shares during the period. Concurrent Investment Advisors LLC grew its holdings in HCA Healthcare by 14.5% during the second quarter. Concurrent Investment Advisors LLC now owns 3,197 shares of the company’s stock worth $1,246,000 after acquiring an additional 404 shares during the period. Finally, NEOS Investment Management LLC lifted its holdings in HCA Healthcare by 12.0% in the 2nd quarter. NEOS Investment Management LLC now owns 25,349 shares of the company’s stock valued at $9,883,000 after acquiring an additional 2,724 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
HCA Healthcare Stock Down 0.8% Shares of NYSE:HCA opened at $401.80 on Wednesday. The company has a market cap of $86.99 billion, a P/E ratio of 13.45, a price-to-earnings-growth ratio of 1.33 and a beta of 1.10. The company’s fifty day moving average is $403.82 and its two-hundred day moving average is $434.97. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the company posted $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. Equities research analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year. HCA Healthcare Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.
Analysts Set New Price Targets A number of research firms recently commented on HCA. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. TD Cowen dropped their price target on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Oppenheimer reduced their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a research report on Tuesday, July 14th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of HCA Healthcare in a research report on Friday. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $462.64.
Read Our Latest Analysis on HCA Healthcare
About HCA Healthcare (Free Report)
HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.
The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.
HCA Healthcare was founded in 1968 by Dr.
See Also Five stocks we like better than HCA Healthcare Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
HCA Healthcare (NYSE:HCA – Get Free Report) and OPKO Health (NASDAQ:OPK – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.
Valuation & Earnings This table compares HCA Healthcare and OPKO Health”s revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HCA Healthcare $75.60 billion 1.15 $6.78 billion $29.87 13.45 OPKO Health $606.90 million 1.96 -$225.68 million ($0.09) -17.67 HCA Healthcare has higher revenue and earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks. Profitability This table compares HCA Healthcare and OPKO Health’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets HCA Healthcare 8.77% -244.79% 11.10% OPKO Health -12.40% -5.88% -3.83% Analyst Recommendations This is a breakdown of recent ratings for HCA Healthcare and OPKO Health, as reported by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HCA Healthcare 1 8 14 0 2.57 OPKO Health 1 3 1 0 2.00 HCA Healthcare currently has a consensus target price of $462.64, indicating a potential upside of 15.14%. OPKO Health has a consensus target price of $1.55, indicating a potential downside of 2.52%. Given HCA Healthcare’s stronger consensus rating and higher probable upside, analysts clearly believe HCA Healthcare is more favorable than OPKO Health.
Volatility & Risk HCA Healthcare has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500.
Insider and Institutional Ownership 62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 64.6% of OPKO Health shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by company insiders. Comparatively, 44.7% of OPKO Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary HCA Healthcare beats OPKO Health on 9 of the 14 factors compared between the two stocks.
About HCA Healthcare (Get Free Report)
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
About OPKO Health (Get Free Report)
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Ryan Specialty (NYSE:RYAN – Get Free Report) and Loews (NYSE:L – Get Free Report) are both large-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.
Valuation and Earnings This table compares Ryan Specialty and Loews”s gross revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ryan Specialty $3.22 billion 3.25 $63.40 million $0.72 56.70 Loews $18.45 billion 1.20 $1.67 billion $8.16 13.27 Loews has higher revenue and earnings than Ryan Specialty. Loews is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks. Dividends Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.3%. Loews pays an annual dividend of $0.25 per share and has a dividend yield of 0.2%. Ryan Specialty pays out 72.2% of its earnings in the form of a dividend. Loews pays out 3.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has increased its dividend for 1 consecutive years. Ryan Specialty is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Volatility & Risk Ryan Specialty has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Loews has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500.
Insider & Institutional Ownership 84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 58.3% of Loews shares are owned by institutional investors. 52.0% of Ryan Specialty shares are owned by insiders. Comparatively, 19.0% of Loews shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability This table compares Ryan Specialty and Loews’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Ryan Specialty 7.55% 43.97% 4.78% Loews 9.02% 8.60% 1.96% Analyst Recommendations This is a summary of current ratings and target prices for Ryan Specialty and Loews, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ryan Specialty 1 10 8 0 2.37 Loews 0 0 0 1 4.00 Ryan Specialty currently has a consensus target price of $53.86, suggesting a potential upside of 31.94%. Given Ryan Specialty’s higher possible upside, equities analysts clearly believe Ryan Specialty is more favorable than Loews.
Summary Ryan Specialty beats Loews on 11 of the 18 factors compared between the two stocks.
About Ryan Specialty (Get Free Report)
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.
About Loews (Get Free Report)
Loews Corporation provides commercial property and casualty insurance in the United States and internationally. The company offers specialty insurance products, such as management and professional liability, and other coverage products; surety and fidelity bonds; property insurance products that include standard and excess property, marine and boiler, and machinery coverages; and casualty insurance products, such as workers' compensation, general and product liability, and commercial auto, surplus, and umbrella coverages. It also provides loss-sensitive insurance programs; and warranty, risk management, information, and claims administration services. The company markets its insurance products and services through independent agents, brokers, and managing general underwriters. In addition, the company is involved in the transportation and storage of natural gas and natural gas liquids, and hydrocarbons through natural gas pipelines covering approximately 13,455 miles of interconnected pipelines; 855 miles of NGL pipelines in Louisiana and Texas; 14 underground storage fields with an aggregate gas capacity of approximately 199.5 billion cubic feet of natural gas; and eleven salt dome caverns and related brine infrastructure for providing brine supply services. Further, the company operates a chain of 25 hotels; and develops, manufactures, and markets a range of extrusion blow-molded and injection molded plastic containers for customers in the pharmaceutical, dairy, household chemicals, food/nutraceuticals, industrial/specialty chemicals, and water and beverage/juice industries, as well as manufactures commodity and differentiated plastic resins from recycled plastic materials. Loews Corporation was incorporated in 1969 and is headquartered in New York, New York.
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
Concurrent Investment Advisors LLC acquired a new position in shares of The New York Times Company (NYSE:NYT – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 36,655 shares of the company’s stock, valued at approximately $2,565,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Navalign LLC bought a new stake in shares of New York Times during the 4th quarter valued at approximately $25,000. Basecamp Wealth Advisors LLC lifted its stake in New York Times by 1,191.7% in the 1st quarter. Basecamp Wealth Advisors LLC now owns 310 shares of the company’s stock valued at $26,000 after purchasing an additional 286 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in New York Times in the fourth quarter valued at approximately $32,000. Larson Financial Group LLC boosted its position in New York Times by 59.6% in the third quarter. Larson Financial Group LLC now owns 656 shares of the company’s stock valued at $38,000 after buying an additional 245 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in shares of New York Times by 690.7% during the first quarter. Geneos Wealth Management Inc. now owns 846 shares of the company’s stock worth $42,000 after buying an additional 739 shares during the last quarter. Institutional investors and hedge funds own 95.37% of the company’s stock.
Wall Street Analysts Forecast Growth A number of research analysts recently issued reports on NYT shares. UBS Group set a $75.00 price objective on shares of New York Times in a report on Tuesday, August 18th. Barclays decreased their price target on shares of New York Times from $66.00 to $63.00 and set an “equal weight” rating for the company in a research report on Thursday, August 6th. Wall Street Zen downgraded shares of New York Times from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Weiss Ratings reiterated a “buy (b)” rating on shares of New York Times in a report on Friday, July 17th. Finally, Zacks Research cut shares of New York Times from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.33.
Check Out Our Latest Stock Analysis on New York Times New York Times News Summary Here are the key news stories impacting New York Times this week:
Positive Sentiment: Election coverage should support engagement. Extensive reporting on the New Hampshire Senate primary, the 2026 midterms, Republican candidates and key congressional races gives NYT opportunities to attract recurring readers during an important political news cycle. New Hampshire U.S. Senate Primary Election Results Positive Sentiment: The company is demonstrating content breadth across major news events. Reporting on tariffs between the United States and Canada, mail voting, Russia’s attack on Kyiv and China’s Arctic shipping route reinforces NYT’s role as a destination for breaking national and international news. Trump Hits Back as Canada Imposes New Tariffs on U.S. Goods Positive Sentiment: The Athletic and entertainment coverage add subscription appeal. U.S. Open updates, MLB analysis, Broadway news and film coverage broaden the company’s appeal beyond hard news and may help retention across its bundle of digital products. US Open 2026 live updates New York Times Stock Up 0.8% Shares of NYSE NYT opened at $67.79 on Wednesday. The company has a market capitalization of $10.93 billion, a PE ratio of 28.25, a P/E/G ratio of 1.75 and a beta of 0.92. The New York Times Company has a twelve month low of $54.10 and a twelve month high of $87.10. The firm has a fifty day simple moving average of $70.25 and a 200 day simple moving average of $75.34.
New York Times (NYSE:NYT – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. New York Times had a net margin of 13.19% and a return on equity of 22.64%. The business had revenue of $762.46 million for the quarter, compared to analysts’ expectations of $752.01 million. During the same quarter in the prior year, the firm posted $0.58 earnings per share. The business’s quarterly revenue was up 11.2% compared to the same quarter last year. As a group, equities analysts expect that The New York Times Company will post 2.82 earnings per share for the current fiscal year.
New York Times Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Thursday, July 23rd. Investors of record on Wednesday, July 8th were given a dividend of $0.23 per share. The ex-dividend date was Wednesday, July 8th. This represents a $0.92 annualized dividend and a dividend yield of 1.4%. New York Times’s dividend payout ratio is presently 38.33%.
New York Times Profile (Free Report)
The New York Times Company is a publicly traded media organization best known for publishing The New York Times newspaper and operating the NYTimes.com digital platform. The company produces daily print and digital journalism covering national and international news, opinion pieces, feature stories, and multimedia content. Alongside its flagship newspaper, the firm offers a range of subscription-based services, including Times Cooking, NYT Games, podcasts and newsletters, designed to engage a broad audience of readers and advertisers.
Founded in 1851 by Henry Jarvis Raymond and George Jones, The New York Times has built a reputation for in-depth reporting and investigative journalism.
Featured Stories Five stocks we like better than New York Times Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for New York Times Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New York Times and related companies with MarketBeat.com's FREE daily email newsletter.
Concurrent Investment Advisors LLC raised its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 695.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,521 shares of the biopharmaceutical company’s stock after purchasing an additional 6,576 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $2,264,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Norges Bank bought a new position in shares of Alnylam Pharmaceuticals in the fourth quarter valued at about $895,816,000. Legal & General Group Plc bought a new stake in shares of Alnylam Pharmaceuticals during the 2nd quarter worth about $278,321,000. Qube Research & Technologies Ltd acquired a new position in Alnylam Pharmaceuticals in the 3rd quarter valued at about $369,943,000. AQR Capital Management LLC grew its stake in Alnylam Pharmaceuticals by 295.2% in the 3rd quarter. AQR Capital Management LLC now owns 744,008 shares of the biopharmaceutical company’s stock valued at $336,009,000 after buying an additional 555,759 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new position in Alnylam Pharmaceuticals in the 2nd quarter valued at about $148,128,000. 92.97% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth Several equities research analysts have issued reports on ALNY shares. BMO Capital Markets restated an “outperform” rating on shares of Alnylam Pharmaceuticals in a research report on Monday, August 31st. TD Cowen reaffirmed a “buy” rating on shares of Alnylam Pharmaceuticals in a research report on Monday, August 31st. Royal Bank Of Canada dropped their price target on Alnylam Pharmaceuticals from $445.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, July 31st. Weiss Ratings upgraded Alnylam Pharmaceuticals from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 31st. Finally, Needham & Company LLC decreased their price objective on Alnylam Pharmaceuticals from $510.00 to $357.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Two research analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Alnylam Pharmaceuticals currently has a consensus rating of “Moderate Buy” and a consensus price target of $382.96.
Read Our Latest Report on ALNY Alnylam Pharmaceuticals Price Performance Shares of ALNY stock opened at $260.10 on Wednesday. The company has a quick ratio of 2.99, a current ratio of 3.05 and a debt-to-equity ratio of 0.75. Alnylam Pharmaceuticals, Inc. has a twelve month low of $197.81 and a twelve month high of $495.55. The company has a market cap of $34.80 billion, a P/E ratio of 48.35 and a beta of 0.31. The business has a fifty day simple moving average of $257.89 and a 200 day simple moving average of $290.47.
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) last issued its earnings results on Thursday, July 30th. The biopharmaceutical company reported $1.84 EPS for the quarter, topping the consensus estimate of $1.63 by $0.21. The firm had revenue of $1.29 billion during the quarter, compared to the consensus estimate of $1.32 billion. Alnylam Pharmaceuticals had a return on equity of 84.93% and a net margin of 15.26%.The business’s quarterly revenue was up 66.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.51) earnings per share. On average, sell-side analysts forecast that Alnylam Pharmaceuticals, Inc. will post 6.71 EPS for the current fiscal year.
(Free Report)
Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics. Founded to translate the scientific discovery of RNAi into new medicines, Alnylam applies small interfering RNA (siRNA) technology to silence disease-causing genes. The company develops therapies designed to provide durable disease modification by targeting underlying genetic drivers across a range of rare and more prevalent conditions.
Alnylam has advanced multiple siRNA-based products into commercialization, initially using lipid nanoparticle delivery and more recently employing GalNAc-conjugate chemistry to enable targeted delivery to the liver with subcutaneous dosing.
Featured Stories Five stocks we like better than Alnylam Pharmaceuticals Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding ALNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report).
Receive News & Ratings for Alnylam Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
GEA Group Aktiengesellschaft (OTCMKTS:GEAGY – Get Free Report) and Terex (NYSE:TEX – Get Free Report) are both mid-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.
Profitability This table compares GEA Group Aktiengesellschaft and Terex’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets GEA Group Aktiengesellschaft -3.20% -7.43% -2.78% Terex 2.23% 12.24% 5.16% Analyst Ratings This is a breakdown of current recommendations for GEA Group Aktiengesellschaft and Terex, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GEA Group Aktiengesellschaft 0 1 1 0 2.50 Terex 0 5 5 2 2.75 Terex has a consensus target price of $78.91, indicating a potential upside of 25.58%. Given Terex’s stronger consensus rating and higher probable upside, analysts clearly believe Terex is more favorable than GEA Group Aktiengesellschaft. Dividends GEA Group Aktiengesellschaft pays an annual dividend of $0.93 per share and has a dividend yield of 2.3%. Terex pays an annual dividend of $0.68 per share and has a dividend yield of 1.1%. GEA Group Aktiengesellschaft pays out -80.2% of its earnings in the form of a dividend. Terex pays out 34.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Terex has raised its dividend for 5 consecutive years. GEA Group Aktiengesellschaft is clearly the better dividend stock, given its higher yield and lower payout ratio.
Volatility and Risk GEA Group Aktiengesellschaft has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Terex has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500.
Insider & Institutional Ownership 0.3% of GEA Group Aktiengesellschaft shares are held by institutional investors. Comparatively, 92.9% of Terex shares are held by institutional investors. 1.6% of Terex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation This table compares GEA Group Aktiengesellschaft and Terex”s revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GEA Group Aktiengesellschaft $5.47 billion 1.34 -$191.04 million ($1.16) -34.99 Terex $6.68 billion 1.08 $221.00 million $1.96 32.06 Terex has higher revenue and earnings than GEA Group Aktiengesellschaft. GEA Group Aktiengesellschaft is trading at a lower price-to-earnings ratio than Terex, indicating that it is currently the more affordable of the two stocks.
Summary Terex beats GEA Group Aktiengesellschaft on 15 of the 18 factors compared between the two stocks.
(Get Free Report)
GEA Group Aktiengesellschaft engages in the development and production of systems and components for the food processing industry worldwide. It operates in two segments, Business Area Equipment and Business Area Solutions. The Business Area Equipment segment offers separators, valves, pumps, homogenizers, and refrigeration compressors, as well as process technology solutions for food processing and packaging applications; and dairy equipment, feeding systems, and slurry engineering solutions. The Business Area Solutions segment provides process solutions for the dairy, food, beverage, pharma, and chemical industries. The company was formerly known as mg technologies ag and changed its name to GEA Group Aktiengesellschaft in 2005. The company has a strategic partnership with SAP SE. GEA Group Aktiengesellschaft was founded in 1881 and is headquartered in Düsseldorf, Germany.
About Terex (Get Free Report)
Terex Corporation manufactures and sells aerial work platforms and materials processing machinery worldwide. It operates in two segments, Materials Processing (MP) and Aerial Work Platforms (AWP). The MP segment designs, manufactures, services, and markets materials processing and specialty equipment, includes crushers, washing systems, screens, trommels, apron feeders, material handlers, pick and carry cranes, rough terrain cranes, tower cranes, wood processing, biomass and recycling equipment, concrete mixer trucks and concrete pavers, conveyors, and related components and replacement parts under the Terex, Powerscreen, Fuchs, EvoQuip, Canica, Cedarapids, CBI, Simplicity, Franna, Terex Ecotec, Finlay, ProAll, ZenRobotics, Terex Washing Systems, Terex MPS, Terex Jaques, Terex Advance, ProStack, Terex Bid-Well, MDS, and Terex Recycling Systems brands. Its products are used in construction, infrastructure, and recycling projects; quarrying and mining, and material handling applications; maintenance applications to lift equipment or material; and landscaping and biomass production industries. The AWP segment designs, manufactures, services, and markets aerial work platform equipment, utility equipment, and telehandlers under the Terex and Genie brands. Its products include portable material lifts, portable aerial work platforms, trailer-mounted articulating booms, self-propelled articulating and telescopic booms, and scissor lifts, as well as related components and replacement parts for construction and maintenance of industrial, commercial, institutional, and residential buildings and facilities, transmission and distribution lines, construction and foundation drilling applications, and other commercial operations, as well as in tree trimming and various infrastructure projects. The company offers financing solutions to assist customers in the rental, leasing, and acquisition of its products. Terex Corporation was founded in 1933 and is based in Norwalk, Connecticut.
Receive News & Ratings for GEA Group Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GEA Group Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
Arizona State Retirement System grew its holdings in shares of Bloom Energy Corporation (NYSE:BE – Free Report) by 26.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,410 shares of the company’s stock after buying an additional 16,333 shares during the quarter. Arizona State Retirement System’s holdings in Bloom Energy were worth $23,432,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the business. West Family Investments Inc. bought a new stake in Bloom Energy in the second quarter worth $303,000. Waverly Advisors LLC bought a new stake in shares of Bloom Energy in the 2nd quarter worth about $599,000. Light Street Capital Management LLC lifted its holdings in shares of Bloom Energy by 66.3% in the 2nd quarter. Light Street Capital Management LLC now owns 84,167 shares of the company’s stock worth $25,477,000 after acquiring an additional 33,542 shares during the last quarter. Nykredit A S purchased a new position in shares of Bloom Energy during the 2nd quarter worth about $26,938,000. Finally, HighTower Advisors LLC boosted its stake in shares of Bloom Energy by 1.1% during the 2nd quarter. HighTower Advisors LLC now owns 67,460 shares of the company’s stock worth $20,420,000 after purchasing an additional 737 shares during the period. Institutional investors own 77.04% of the company’s stock.
Analyst Upgrades and Downgrades A number of research firms recently weighed in on BE. JPMorgan Chase & Co. reduced their price objective on shares of Bloom Energy from $346.00 to $314.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 29th. Jefferies Financial Group upped their target price on Bloom Energy from $188.00 to $229.00 and gave the company a “hold” rating in a research note on Friday, August 14th. Barclays increased their price target on Bloom Energy from $254.00 to $276.00 and gave the stock an “equal weight” rating in a report on Tuesday, June 23rd. Susquehanna raised their price target on Bloom Energy from $293.00 to $298.00 and gave the stock a “positive” rating in a research note on Friday, July 10th. Finally, Evercore restated an “outperform” rating on shares of Bloom Energy in a report on Friday, August 7th. Three equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $249.18.
Read Our Latest Analysis on BE Insider Transactions at Bloom Energy In other news, insider Shawn Soderberg sold 2,895 shares of the business’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $233.60, for a total value of $676,272.00. Following the completion of the sale, the insider owned 129,370 shares in the company, valued at approximately $30,220,832. The trade was a 2.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Chambers sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $250.00, for a total transaction of $3,750,000.00. Following the completion of the sale, the director directly owned 208,333 shares of the company’s stock, valued at $52,083,250. The trade was a 6.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 89,464 shares of company stock valued at $22,131,255 over the last three months. 3.00% of the stock is currently owned by corporate insiders.
Bloom Energy Stock Up 9.2% Shares of NYSE BE opened at $276.10 on Wednesday. Bloom Energy Corporation has a 52-week low of $52.00 and a 52-week high of $351.28. The firm has a market capitalization of $81.32 billion, a price-to-earnings ratio of 368.13, a PEG ratio of 3.46 and a beta of 3.80. The stock has a 50 day moving average price of $225.92 and a 200 day moving average price of $223.95. The company has a debt-to-equity ratio of 1.59, a quick ratio of 3.41 and a current ratio of 4.09.
Bloom Energy (NYSE:BE – Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.78 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.39. Bloom Energy had a return on equity of 35.45% and a net margin of 7.87%.The business had revenue of $1.07 billion during the quarter, compared to analyst estimates of $826.13 million. During the same period in the previous year, the company posted $0.10 EPS. Bloom Energy’s revenue was up 165.5% on a year-over-year basis. Bloom Energy has set its FY 2026 guidance at 2.550-2.850 EPS. Sell-side analysts expect that Bloom Energy Corporation will post 1.92 earnings per share for the current year.
Bloom Energy News Roundup Here are the key news stories impacting Bloom Energy this week:
Positive Sentiment: S&P 500 inclusion is the primary catalyst. Bloom Energy will join the index before the market opens on September 21. The change is expected to generate demand from index-tracking funds and increase the company’s visibility among institutional investors. Bloom Energy Rallies on News of S&P 500 Addition Positive Sentiment: AI data-center demand is strengthening the growth outlook. Analysts and financial commentators say Bloom’s fuel-cell systems can provide fast, scalable, on-site power for hyperscale data centers, where grid constraints and permitting delays are increasing demand for alternative solutions. Recent coverage cited record second-quarter revenue above $1 billion, 165.5% year-over-year growth, strong gross margins and higher full-year guidance. Bloom Energy Could See An AI-Memory-Style Frenzy Positive Sentiment: Momentum and estimates remain favorable. BE has outperformed its industry recently, while improving EPS forecasts and investor interest in AI infrastructure have helped reinforce the bullish narrative. The company’s prior quarterly earnings also exceeded consensus estimates on both earnings and revenue. Neutral Sentiment: Valuation leaves little room for disappointment. Commentary noted that the stock has risen sharply over the past year and now trades at a premium valuation. Future performance will depend on whether AI-related orders, backlog growth and earnings expansion can justify the current price. Negative Sentiment: Multiple law firms are promoting a securities class action against Bloom Energy. The lawsuits and investor alerts allege that the company misrepresented its exposure to a China-linked scandium supply chain, despite statements that it had no China supply chain. The lead-plaintiff deadline is September 28, 2026. The allegations have not been proven, but the litigation creates reputational, legal and potential financial risks. Bloom Energy Securities Class Action Alert Bloom Energy Profile (Free Report)
Bloom Energy Corporation develops and manufactures solid oxide fuel cell systems that generate electricity through an electrochemical process. Its primary product, the Bloom Energy Server, is designed to provide on-site, distributed power for commercial and industrial customers, data centers, utilities, and other organizations seeking reliable electricity with lower emissions than conventional fossil-fuel generation.
The company also offers the Bloom Electrolyzer, which uses solid oxide technology to produce hydrogen from electricity and water.
Read More Five stocks we like better than Bloom Energy Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For Want to see what other hedge funds are holding BE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bloom Energy Corporation (NYSE:BE – Free Report).
Receive News & Ratings for Bloom Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bloom Energy and related companies with MarketBeat.com's FREE daily email newsletter.
The largest bottleneck for the artificial intelligence (AI) infrastructure build-out is electricity. That is according to industry leaders, such as Elon Musk, who plans to invest tens of billions in AI data centers at Space Exploration Technologies.
Bloom Energy (BE +9.63%) has been a huge winner during this electricity supply crunch, with its fuel-cell power solution utilized by data centers. It all comes down to the fact that Bloom Energy can bring power quickly to a data center, and in fact, it delivered power to an Oracle data center in just 55 days this year.
Here's why speed is so important for electric power deployments in 2026 and whether Bloom Energy has built a sustainable business as the leading fuel cell provider for data centers.
Premium Feature
Moneyball Superscore
81/100
Today's Change
(
9.63
%) $
24.35
Current Price
$
277.22
Quickly bringing on-site power to data centers Bloom builds modular electric power systems housing fuel cells. The systems use a fuel source, primarily natural gas, and convert it to electricity, with no particulate pollutants like traditional generators. This can be helpful to data center owners in two ways.
First, Bloom Energy can quickly deliver electricity to a data center when it is first constructed, whereas connecting to the broader power grid may take years. For its recent Oracle deployment, Bloom said that it got the system up and running in just 55 days. This makes Bloom Energy a perfect bridge before a data center complex can connect to the actual power grid.
Second, Bloom's fuel cells can provide backup power in the event of an outage, and data center owners want as close to 100% uptime as possible to ensure there are no disruptions for their end software customers.
There has been a boom in demand for Bloom's products across the myriad data centers being built throughout the U.S. Revenue rose 166% year over year last quarter to a little more than $1 billion, mainly from product revenue sales and significantly beating analyst estimates. Importantly, Bloom says its backlog is growing much faster than revenue and won't be depleted for many years.
Image source: Getty Images.
Service revenue can drive stable earnings Investors might think Bloom Energy will have only a temporary growth spurt in this immense data center build-out before falling back to Earth. This underestimates the length of its customer contracts.
When signing deals with data centers, Bloom Energy plans to provide its fuel cells on-site for more than a decade, even if they are only used as backup generators. This can mean service revenue for years that spans energy usage, maintenance, and systems monitoring by Bloom Energy.
Its order backlog at the end of 2025 was $20 billion, with $14 billion of that coming from future services revenue. As long as Bloom Energy remains the primary fuel cell provider for data centers and other sectors, such as large retail outlets, it should maintain stable earnings power, especially if it can increase the number of modular units deployed worldwide.
One risk with Bloom Energy stock today With soaring demand, Bloom Energy's stock price is up more than 1,000% during the past five years, reaching a market cap of roughly $82 billion as investors grow optimistic about modular power deployment at data centers.
The main risk for Bloom Energy is fairly obvious: that in data center build-out growth slows down significantly. This could occur for many reasons, including a lack of capital for AI infrastructure, innovations in efficiency for AI use cases, or slowing growth in end-customer usage.
Bloom's business wouldn't fall apart given its long-term contracts discussed. However, with the stock currently trading at a lofty price-to-sales ratio (P/S) of 22 for a low-margin energy business, missing Wall Street's expectations could lead to a collapse in its share price.
San Diego, California--(Newsfile Corp. - September 9, 2026) - Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026 (the "Class Period"). Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to stabilize the zirconia-based ceramic electrolyte in the Company's solid oxide fuel cells.
The lawsuit alleges that Bloom Energy misled investors regarding the source of its materials.
Investors who suffered losses during the Class Period may have legal rights. The deadline to seek appointment as lead plaintiff is September 28, 2026.
Listen to our podcast.
Why Was Bloom Energy Sued?
According to the complaint, Bloom Energy described the Company's supply chain as not being dependent on China. The lawsuit alleges that Bloom Energy and certain defendants failed to adequately disclose that the Company was in fact reliant on Chinese scandium.
According to plaintiff, defendants failed to disclose that:
Bloom Energy obtained scandium through intermediaries who sourced the metal from China; the Company understated the extent to which it relied on scandium from China; and as a result, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.What Did Bloom Energy Say About its Reliance on China
The complaint alleges that several times during the class period, defendants reiterated that Bloom Energy was not reliant on China. Specifically:
February 27, 2025 - Bloom Energy stated in its annual report for the fiscal year ended December 31, 2024 on a Form 10-K filed with the SEC that the Company's "supply chain does not have significant exposure to China."
April 30, 2025 - on an earnings call in connection with the Company's first quarter 2025 financial results, defendant Sridhar stated that "there is no China supply chain for us" and "we are not dependent on China for scandium."
July 31, 2025 - Bloom Energy stated in its quarterly report for the period ended June 30, 2025 on a Form 10-Q filed with the SEC that the Company's "supply chain does not have significant exposure to China."
September 12, 2025 - Media outlet Semafor published an article containing an interview with defendant Sridhar in which Sridhar alleged "Starting in 2004, we said we are not going to depend on a Chinese supply chain. If we believe in energy abundance for all, there cannot be a single source to strangle you."
October 28, 2025 - Bloom Energy stated in its quarterly report for the period ended September 30, 2025 on a Form 10-Q filed with the SEC that the Company's "supply chain does not have significant exposure to China."
February 5, 2026 - Bloom Energy stated in its annual report for the fiscal year ended December 31, 2025 on a Form 10-K filed with the SEC that Company's "supply chain does not have significant exposure to China" and purported to assured investors China merely "supplies multiple components including rare earth metals and compounds used in electronic and electromechanical components that are part of our tier 2 and tier 3 sub-assembly suppliers."
June 10, 2026 - The Wall Street Journal published a video interview with defendant Sridhar in which Sridhar confirmed that one of the notable countries Bloom Energy is not sourcing from is China. Sridhar explained that "early on in the company we made a decision that we are only going to depend on supply chains that we can completely trust and that [China] was a country we avoided."
July 7, 2026 - Bloom Energy published a blog post authored by its COO in which they discussed the resiliency of Bloom Energy's supply chain and noted that the Company sources scandium from multiple sources.
Why Did BE Stock Collapse?
This complaint alleges that the collapse of Bloom Energy's stock followed the publication of an article by Hunterbrook Media entitled "Bloom's Big Lie." The Report alleged that Bloom Energy is "in fact, reliant on Chinese scandium."
Hunterbrook "found four separate trade routes that appear to show Chinese scandium is still part of Bloom's supply chain, and the material is reaching the U.S. through intermediary countries." Based on conversations with a major scandium producer in China (who claimed to be Bloom Energy's largest supplier) and commercially available trade data, the Report claimed that Bloom Energy received scandium directly from China on 4 occasions between August 2023 and May 2024."
On this news, Bloom's stock price fell $15.28, or 5.7%, to close at $254.29 per share on July 8, 2026.
Who May Be Eligible?
The lawsuit seeks to represent investors who purchased or otherwise acquired Bloom Energy Corporation (BE) securities during the applicable Class Period. If you purchased Bloom Energy stock during this period and suffered investment losses, you may have rights under the federal securities laws.
What Is a Lead Plaintiff?
The lead plaintiff is the investor appointed by the court to represent the interests of the proposed class throughout the litigation. Investors do not have to serve as lead plaintiff to potentially share in any recovery if the lawsuit is successful.
If you are interested in seeking appointment as lead plaintiff, you must submit your papers with the court by September 28, 2026.
Does it Cost Anything to Participate?
No. Robbins LLP represents investors on a contingency fee basis. Investors never pay attorneys' fees or litigation expenses. If there is a recovery, defendants pay fees and expenses.
Contact Robbins LLP
Investors seeking additional information about the Bloom Energy securities class action may submit an inquiry through Robbins LLP's website, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
About Robbins LLP
A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.
"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.
To be notified if a class action against Bloom Energy Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Facebook
LinkedIn
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/313407
Source: Robbins LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Concurrent Investment Advisors LLC boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 77.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,565 shares of the medical equipment provider’s stock after purchasing an additional 24,166 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Boston Scientific were worth $2,371,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Renaissance Group LLC purchased a new stake in Boston Scientific in the fourth quarter valued at approximately $28,064,000. Perigon Wealth Management LLC acquired a new position in shares of Boston Scientific in the 2nd quarter valued at $883,000. Y Intercept Hong Kong Ltd raised its position in Boston Scientific by 148.8% in the 2nd quarter. Y Intercept Hong Kong Ltd now owns 1,120,331 shares of the medical equipment provider’s stock valued at $47,816,000 after purchasing an additional 670,060 shares during the last quarter. Wealthfront Advisers LLC purchased a new position in Boston Scientific during the 2nd quarter worth $3,253,000. Finally, PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Boston Scientific by 9.9% in the second quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 320,038 shares of the medical equipment provider’s stock valued at $13,659,000 after purchasing an additional 28,961 shares during the period. Institutional investors and hedge funds own 89.07% of the company’s stock.
Boston Scientific Stock Down 5.9% Boston Scientific stock opened at $45.00 on Wednesday. The stock’s 50 day moving average price is $47.04 and its 200 day moving average price is $55.18. Boston Scientific Corporation has a 1-year low of $42.20 and a 1-year high of $109.50. The company has a market cap of $65.22 billion, a PE ratio of 18.22, a price-to-earnings-growth ratio of 1.10 and a beta of 0.57. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.24 and a quick ratio of 0.74.
Boston Scientific (NYSE:BSX – Get Free Report) last issued its earnings results on Wednesday, July 29th. The medical equipment provider reported $0.86 EPS for the quarter, topping the consensus estimate of $0.83 by $0.03. The company had revenue of $5.44 billion for the quarter, compared to analyst estimates of $5.38 billion. Boston Scientific had a net margin of 17.50% and a return on equity of 19.28%. The business’s revenue was up 7.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.75 EPS. Boston Scientific has set its Q3 2026 guidance at 0.800-0.820 EPS and its FY 2026 guidance at 3.280-3.320 EPS. On average, sell-side analysts predict that Boston Scientific Corporation will post 3.3 EPS for the current fiscal year. Boston Scientific announced that its board has approved a stock repurchase plan on Monday, May 18th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the medical equipment provider to purchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its shares are undervalued.
Key Stories Impacting Boston Scientific Here are the key news stories impacting Boston Scientific this week:
Positive Sentiment: Boston Scientific said manufacturing and shipping operations are recovering, which could limit the disruption and support a gradual rebound in revenue and profitability. The company also expects multiple product launches and cost savings to aid longer-term growth. Boston Scientific Says It Won’t Meet 2026 Guidance After Cyberattack Neutral Sentiment: The company has not provided a replacement forecast, leaving investors without clear visibility into the size or duration of the financial impact. Management’s ability to restore systems and normalize shipments will be key near-term catalysts. Boston Scientific says cyberattack likely to hurt 2026 sales, profit Negative Sentiment: Boston Scientific said it is unlikely to meet its 2026 net-sales growth and earnings-per-share guidance ranges, including its previously issued third-quarter and full-year outlook. That reversal is driving the stock’s decline because it signals weaker near-term revenue, profit and cash-flow expectations. Boston Scientific Won’t Meet Guidance Due to Cyberattack Negative Sentiment: The incident adds operational and execution risk to pressure already affecting parts of the portfolio, including WATCHMAN and electrophysiology products. Investors are now likely to focus on the timing of the recovery, the ultimate size of the earnings shortfall and whether customer orders can be fully restored. Boston Scientific’s 2026 Growth Outlook Weakens Insider Activity In other news, Director David C. Habiger bought 2,100 shares of the firm’s stock in a transaction on Wednesday, August 5th. The shares were bought at an average cost of $47.59 per share, for a total transaction of $99,939.00. Following the completion of the transaction, the director owned 17,160 shares in the company, valued at $816,644.40. This trade represents a 13.94% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Edward J. Ludwig purchased 5,000 shares of the business’s stock in a transaction dated Friday, July 31st. The shares were purchased at an average cost of $45.48 per share, with a total value of $227,400.00. Following the purchase, the director directly owned 30,359 shares in the company, valued at approximately $1,380,727.32. The trade was a 19.72% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders purchased 194,522 shares of company stock worth $9,385,210. Company insiders own 0.34% of the company’s stock.
Analyst Ratings Changes Several equities research analysts have recently weighed in on the stock. Wolfe Research downgraded shares of Boston Scientific from an “outperform” rating to a “peer perform” rating in a research note on Friday, May 29th. Weiss Ratings cut Boston Scientific from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, July 7th. Robert W. Baird set a $56.00 target price on Boston Scientific in a report on Thursday, July 30th. Citigroup decreased their price target on Boston Scientific from $70.00 to $61.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Finally, Needham & Company LLC dropped their price objective on shares of Boston Scientific from $77.00 to $57.00 and set a “buy” rating on the stock in a research note on Wednesday, July 8th. Twenty-four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $71.62.
Read Our Latest Stock Report on BSX
Boston Scientific Company Profile (Free Report)
Boston Scientific Corporation is a medical device company that develops, manufactures and markets products used in minimally invasive procedures. Its technologies are designed to diagnose and treat a range of medical conditions while supporting less invasive alternatives to traditional surgery.
The company’s products address cardiovascular, endoscopy, urology, pelvic health and neuromodulation applications. Its portfolio includes devices used in cardiac rhythm management and electrophysiology, structural heart procedures, peripheral and vascular interventions, gastrointestinal procedures, kidney stone and prostate treatments, and therapies for chronic pain and other neurological conditions.
Founded in 1979, Boston Scientific serves healthcare providers and patients in markets around the world.
Read More Five stocks we like better than Boston Scientific Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
, /PRNewswire/ -- THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2026 fourth quarter earnings release will be on Tuesday, September 22, 2026, before the market opens.
Upon the release of THOR's fiscal 2026 fourth quarter earnings, the Company will concurrently publish a copy of the earnings release, a comprehensive question and answer document and a slide presentation on the Company's website. To view the quarterly earnings documents, please go to http://ir.thorindustries.com/.
About THOR Industries, Inc.
THOR Industries is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles.
For more information on the Company and its products, please go to www.thorindustries.com.
Forward-Looking Statements
This release includes certain statements that are "forward-looking" statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made based on management's current expectations and beliefs regarding future and anticipated developments and their effects upon THOR and inherently involve uncertainties and risks. These forward-looking statements are not a guarantee of future performance and actual results may differ materially from our expectations. Factors which could cause materially different results include, among others: the impact of inflation on the cost of our products as well as on general consumer demand; the effect of raw material and commodity price fluctuations, including the impact of tariffs, and/or raw material, commodity or chassis supply constraints; the impact of war, military conflict, terrorism and/or cyber-attacks, including state-sponsored or ransom attacks; the impact of sudden or significant adverse changes in the cost and/or availability of energy or fuel, including those caused by geopolitical events, on our costs of operation, on raw material prices, on our suppliers, on our independent dealers or on retail customers; the dependence on a small group of suppliers for certain components used in production, including chassis; interest rates and interest rate fluctuations and their potential impact on the general economy and, specifically, on our independent dealers and consumers and our profitability; the ability to ramp production up or down quickly in response to rapid changes in demand or market share while also managing associated costs, including labor-related costs and production capacity costs; the level and magnitude of warranty and recall claims incurred; the ability of our suppliers to financially support any defects in their products; the financial health of our independent dealers and their ability to successfully manage through various economic conditions; legislative, trade, regulatory and tax law and/or policy developments including their potential impact on our independent dealers, retail customers or on our suppliers; the costs of compliance with governmental regulation; the impact of an adverse outcome or conclusion related to current or future litigation or regulatory audits or investigations; public perception of and the costs related to environmental, social and governance matters; legal and compliance issues including those that may arise in conjunction with recently completed transactions; the ability to realize anticipated benefits of strategic initiatives including realignments or other reorganizational actions; the level of consumer confidence and the level of discretionary consumer spending; the impact of exchange rate fluctuations; restrictive lending practices which could negatively impact our independent dealers and/or retail consumers; management changes; the success of new and existing products and services; the ability to maintain strong brands and develop innovative products that meet consumer demands; changes in consumer preferences; the risks associated with acquisitions, including: the pace and successful closing of an acquisition, the integration and financial impact thereof, the level of achievement of anticipated operating synergies from acquisitions, the potential for unknown or understated liabilities related to acquisitions, the potential loss of existing customers of acquisitions and our ability to retain key management personnel of acquired companies; a shortage of necessary personnel for production and increasing labor costs and related employee benefits costs to attract and retain production personnel in times of high demand; the loss or reduction of sales to key independent dealers, and stocking level decisions of our independent dealers; disruption of the delivery of units to independent dealers or the disruption of delivery of raw materials, including chassis, to our facilities; increasing costs for freight and transportation; the ability to protect our information technology systems, including confidential and personal information, from data breaches, cyber-attacks and/or network disruptions; asset impairment charges; competition; the impact of losses under repurchase agreements; the impact of the strength of the U.S. dollar on international demand for products priced in U.S. dollars; general economic, market, public health and political conditions in the various countries in which our products are produced and/or sold; the impact of adverse weather conditions and/or weather-related events; the impact of changing emissions and other related climate change regulations in the various jurisdictions in which our products are produced, used and/or sold; changes to our investment and capital allocation strategies or other facets of our strategic plan; and changes in market liquidity conditions, credit ratings and other factors that may impact our access to future funding and the cost of debt.
These and other risks and uncertainties are discussed more fully in our Quarterly Report on Form 10-Q for the quarter ended April 30, 2026 and in Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2025.
We disclaim any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this release or to reflect any change in our expectations after the date hereof or any change in events, conditions or circumstances on which any statement is based, except as required by law.
In the latest close session, M/I Homes (MHO - Free Report) was down 3.35% at $143.29. The stock fell short of the S&P 500, which registered a loss of 0.58% for the day. On the other hand, the Dow registered a loss of 1.18%, and the technology-centric Nasdaq decreased by 0.32%.
Coming into today, shares of the homebuilder had gained 0.11% in the past month. In that same time, the Construction sector lost 7.66%, while the S&P 500 lost 0.36%.
Analysts and investors alike will be keeping a close eye on the performance of M/I Homes in its upcoming earnings disclosure. The company is forecasted to report an EPS of $3.15, showcasing a 23.91% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $1.1 billion, indicating a 2.78% downward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $12.5 per share and revenue of $4.2 billion, indicating changes of -15.2% and -4.86%, respectively, compared to the previous year.
Investors should also pay attention to any latest changes in analyst estimates for M/I Homes. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. M/I Homes presently features a Zacks Rank of #3 (Hold).
From a valuation perspective, M/I Homes is currently exchanging hands at a Forward P/E ratio of 11.86. This valuation marks a discount compared to its industry average Forward P/E of 13.59.
The Building Products - Home Builders industry is part of the Construction sector. At present, this industry carries a Zacks Industry Rank of 92, placing it within the top 38% of over 250 industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
